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Functional and structural analysis of the activation mechanism of
Caspase-8
Abstract
Human caspase-8 is an enzyme involved in apoptosis, a process essential to remove unwanted or
diseased cells throughout the life of multicellular organisms. Initially caspase-8 is produced in the cell as
the monomeric latent precursor procaspase-8 comprising an N-terminal prodomain with two death
effector domains followed by a catalytic domain that contains two subunits connected by a 40 amino
acid linker. The catalytic domain harbors the substrate binding pocket and the active site residue
cysteine. Activation of the enzyme occurs upon binding of the zymogen to the macromolecular death
inducing signaling complex, DISC. This binding is facilitated by homotypic death effector domain
interactions between the prodomain of procaspase-8 and the adapter protein FADD. Bound to the DISC
procaspase-8 becomes activated by dimerization and subsequent proteolytic processing. This thesis
analyzes the activation mechanism of caspase-8 in more detail using biochemical and biophysical as
well as structural methods. Thereby, chapter 2 focuses on the prodomain and its binding to FADD
whereas chapters 3 and 4 analyze the structural changes occurring within the catalytic domain of
caspase-8. The determinants for binding of procaspase-8 prodomain to FADD were analyzed using
pull-down experiments. It was shown that FADD binding depends on the complete prodomain since
individual death effector domains were not able to bind FADD. During purification and pull-down
experiments an additional oligomerization of the prodomains was evident. An initial hypothesis stated
that this oligomerization is cysteine dependent. However, mutation of two cysteins in the second death
effector domain of the prodomain of caspase-8 could not confirm this, neither with pull-down
experiments nor in cell biological assays. Preliminary studies using fusion tagged caspase-8 prodomain
and FADD were conducted to form a complex between FADD and the caspase-8 prodomain for
biochemical and structural studies. However, current problems include a high aggregation tendency of
the proteins and the presence of large fusion tags, which might hamper structure determination.
Therefore, a discussion in chapter 2.3 includes several strategies to circumvent these problems in future
experiments. Whereas structure determination of the prodomain proved to be difficult the structure of
the catalytic domain of the caspase-8 zymogen, procaspase-8 was determined by solution NMR.
Whereas the secondary structure elements of procaspase-8 resemble the ones of active caspase-8
significant differences were observed in the loops surrounding the substrate binding pocket and the
linker connecting the two subunits. Biochemical and biophysical analyses on a set of various
dimerization and processing mutants were performed to elucidate the transition from monomeric
procaspase-8 to active dimeric caspase-8 and the influence of inhibitor binding. These studies clearly
confirm the requirement of dimerization for caspase-8 activity in unprocessed but also processed form
by inducing structural changes around the active site. In addition, it was shown that dimerization is
important for activation of the enzyme by relocating the intersubunit linker, which in procaspase-8
covers part of the substrate binding region, into close proximity of the active site of the associated
protomer thus allowing intermolecular cleavage within the dimer. Processing has to occur at both
cleavage sites within the linker to achieve full caspase-8 activity. After processing structural
rearrangements in the active site forming loops and the cleaved linker fragments occur resulting in a
preformed active site. Upon substrate binding this region then undergoes additional changes to
accommodate the substrate. This work clearly confirms the importance of dimerization for activation
and activity of caspase-8. Furthermore, it highlights the additional importance of proteolytic processing
for the activation process. Thus the here described data allow a refinement of the previous model for
caspase-8 activation and most likely provides insights into the activation mechanism of other caspases.
Das Enzym Caspase-8 spielt eine ausschlaggebende Rolle in der Apoptose, einem Prozess welcher für
die Eliminierung von kranken oder überschüsssigen Zellen in mehrzelligen Organismen verantwortlich
ist. In der Zelle wird Caspase-8 zunächst als inaktives Zymogen, sogenannte Procaspase- 8, produziert.
In dieser Form besteht das Enzym aus einer N-terminalen Prodomäne mit zwei Todeseffektordomänen
und einer C-terminalen katalytischen Domäne, welche in zwei Untereinheiten unterteilt ist und die
Substratbingungsstelle und das katalytische Cystein enthält. Die Aktivierung von Caspase-8 erfolgt
durch Bindung der Prodomäne an das Adapterprotein FADD welches Teil eines hochmolekularen
Komplexes genannt DISC (death inducing signaling complex) ist. Dort wird durch Dimerisierung und
proteolytische Spaltung das aktive Enzym gebildet. Diese Doktorarbeit beschreibt biochemische,
biophysikalische und strukturelle Experimente zur Untersuchung des detailierten
Aktivierungsmechanismus der Caspase-8. Im Wesentlichen enthält diese Arbeit zwei Hauptteile: Im
Kapitel 2 wird die Interaktion zwischen der Prodomäne und FADD genauer analysiert, während in den
Kapiteln 3 und 4 die strukturellen Änderungen in der katalytischen Domäne während des
Aktiverungsprozesses genauer untersucht werden. Die Bindung zwischen der Prodomäne der Caspase-8
und FADD wurde durch biochemische Interaktionsstudien analysiert. Darin wurde gezeigt, dass beide
Todeseffektordomänen der Prodomäne benötig werden um FADD zu binden, da keine Bindung durch
individuelle Todeseffektordomänen erfolgte. Während der Proteinreinigung und der Interaktionsstudien
wurde wiederholt eine Oligomerisation der Prodomäne beobachtet, welche ursprünglich auf die
Ausbildung von Disulfidbrücken zwischen den Prodomänen zurückgeführt wurde. Mutation von zwei
Cysteinen in der zweiten Todeseffektordomäne zeigte allerdings, dass dieses Phenomän nicht
cysteinabhängig und höchstwahrscheinlich biologisch nicht relevant ist. Erste Versuche zur Expression
und Reinigung eines Komplexes bestehend aus Prodomäne und FADD für biochemische und
strukturelle Charakterisierungen wurden durchgeführt. Allerdings wurden diese Experimente durch eine
hohe Tendenz der Prodomäne zur Aggregation und das Vorhandensein von grossen Fusionsdomänen an
der Prodomäne und am FADD erschwert. Eine ausführliche Diskussion im Kapitel 2.3 beschreibt
verschiedene Strategien, diese Probleme in zukünftigen Experimenten zu bewältigen. Während die
Strukturbestimmung der Prodomäne bis jetzt nicht erfolgreich war, wurde die Struktur der katalytischen
Domäne der inaktiven Procaspase- 8 mittels Kernresonanzspektroskopie bestimmt. Diese Struktur zeigt,
dass die Sekundärstrukturelemente der Procaspase-8 im Vergleich zur Caspase-8 konserviert sind.
Unterschiede zwischen den beiden Strukturen sind in den Loops um die Substratbindungsstelle und dem
Linker zwischen den Untereinheiten der katalytischen Domäne zu finden. Biochemische und
biophysikalische Analysen an verschiedenen Dimerisierungs- und Prozessierungsmutanten erlauben
Einblicke in den strukturellen Übergang von der Procaspase-8 zur Caspase-8 und die Substatbindung an
das Enzym. Diese Experimente deuten darauf hin, dass Dimerisierung eine Umlagerung des Linkers
herbeiführt. In monomerer Procaspase-8 bedeckt ein Teil des Linkers die Stelle, an welcher die
Substratbindungstasche in der aktiven Caspase-8 gebildet wird. Durch die Dimerisierung wird die
Position des Linkers so umgelagert, dass dessen Prozessierungsstellen in die Nähe des katalytischen
Cysteins des zweiten Caspase-8 Moleküles vom gleichen Dimer rücken und somit intermolekulare
Spaltung innerhalb des Dimers ermöglicht wird. Dabei ist es wichtig, dass die Caspase-8 an beiden
Prozessierungsstellen gespalten wird, um die volle Aktivität des Enzyms zu erhalten. Nach der Spaltung
erfolgen strukturelle Änderungen in den Loops an der Substratbindungsstelle und den gespaltenen
Linkerfragmenten. Dadurch wird die Substratbindungstasche teilweise ausgebildet. Weitere
Umlagerungen zur vollständigen Bildung der Bindungstasche erfolgen während der Substratbindung.
Diese Arbeit bestätigt den Einfluss der Dimerisierung auf die Aktivierung und Aktivität der Caspase-8.
Zusätzlich wird deutlich gemacht, dass proteolytische Spaltung eine massgebliche Rolle im
Aktivierungsprozess spielt. Die präsentierten Ergebnisse erlauben ein tieferes Verständniss des
derzeitigen Aktivierungsmechanismusses der Caspase-8 und möglicherweise anderer Caspasen.
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Abstract
Human caspase-8 is an enzyme involved in apoptosis, a process essential to
remove unwanted or diseased cells throughout the life of multicellular or-
ganisms. Initially caspase-8 is produced in the cell as the monomeric latent
precursor procaspase-8 comprising an N-terminal prodomain with two death
effector domains followed by a catalytic domain that contains two subunits
connected by a 40 amino acid linker. The catalytic domain harbors the sub-
strate binding pocket and the active site residue cysteine. Activation of the
enzyme occurs upon binding of the zymogen to the macromolecular death
inducing signaling complex, DISC. This binding is facilitated by homotypic
death effector domain interactions between the prodomain of procaspase-8
and the adapter protein FADD. Bound to the DISC procaspase-8 becomes
activated by dimerization and subsequent proteolytic processing.
This thesis analyzes the activation mechanism of caspase-8 in more detail
using biochemical and biophysical as well as structural methods. Thereby,
chapter 2 focuses on the prodomain and its binding to FADD whereas chap-
ters 3 and 4 analyze the structural changes occurring within the catalytic
domain of caspase-8.
The determinants for binding of procaspase-8 prodomain to FADD were
analyzed using pull-down experiments. It was shown that FADD binding
depends on the complete prodomain since individual death effector domains
were not able to bind FADD. During purification and pull-down experiments
an additional oligomerization of the prodomains was evident. An initial
hypothesis stated that this oligomerization is cysteine dependent. How-
ever, mutation of two cysteins in the second death effector domain of the
prodomain of caspase-8 could not confirm this, neither with pull-down ex-
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periments nor in cell biological assays.
Preliminary studies using fusion tagged caspase-8 prodomain and FADD
were conducted to form a complex between FADD and the caspase-8 pro-
domain for biochemical and structural studies. However, current problems
include a high aggregation tendency of the proteins and the presence of
large fusion tags, which might hamper structure determination. Therefore,
a discussion in chapter 2.3 includes several strategies to circumvent these
problems in future experiments.
Whereas structure determination of the prodomain proved to be difficult the
structure of the catalytic domain of the caspase-8 zymogen, procaspase-8 was
determined by solution NMR. Whereas the secondary structure elements of
procaspase-8 resemble the ones of active caspase-8 significant differences were
observed in the loops surrounding the substrate binding pocket and the linker
connecting the two subunits. Biochemical and biophysical analyses on a set
of various dimerization and processing mutants were performed to elucidate
the transition from monomeric procaspase-8 to active dimeric caspase-8 and
the influence of inhibitor binding. These studies clearly confirm the require-
ment of dimerization for caspase-8 activity in unprocessed but also processed
form by inducing structural changes around the active site. In addition, it
was shown that dimerization is important for activation of the enzyme by
relocating the intersubunit linker, which in procaspase-8 covers part of the
substrate binding region, into close proximity of the active site of the as-
sociated protomer thus allowing intermolecular cleavage within the dimer.
Processing has to occur at both cleavage sites within the linker to achieve
full caspase-8 activity. After processing structural rearrangements in the ac-
tive site forming loops and the cleaved linker fragments occur resulting in
a preformed active site. Upon substrate binding this region then undergoes
additional changes to accommodate the substrate.
This work clearly confirms the importance of dimerization for activation and
activity of caspase-8. Furthermore, it highlights the additional importance
of proteolytic processing for the activation process. Thus the here described
data allow a refinement of the previous model for caspase-8 activation and
most likely provides insights into the activation mechanism of other caspases.
Zusammenfassung
Das Enzym Caspase-8 spielt eine ausschlaggebende Rolle in der Apoptose,
einem Prozess welcher für die Eliminierung von kranken oder überschüss-
sigen Zellen in mehrzelligen Organismen verantwortlich ist. In der Zelle
wird Caspase-8 zunächst als inaktives Zymogen, sogenannte Procaspase-
8, produziert. In dieser Form besteht das Enzym aus einer N-terminalen
Prodomäne mit zwei Todeseffektordomänen und einer C-terminalen kat-
alytischen Domäne, welche in zwei Untereinheiten unterteilt ist und die Sub-
stratbingungsstelle und das katalytische Cystein enthält. Die Aktivierung
von Caspase-8 erfolgt durch Bindung der Prodomäne an das Adapterprotein
FADD welches Teil eines hochmolekularen Komplexes genannt DISC (death
inducing signaling complex) ist. Dort wird durch Dimerisierung und prote-
olytische Spaltung das aktive Enzym gebildet.
Diese Doktorarbeit beschreibt biochemische, biophysikalische und strukturelle
Experimente zur Untersuchung des detailierten Aktivierungsmechanismus
der Caspase-8. Im Wesentlichen enthält diese Arbeit zwei Hauptteile: Im
Kapitel 2 wird die Interaktion zwischen der Prodomäne und FADD genauer
analysiert, während in den Kapiteln 3 und 4 die strukturellen Änderungen
in der katalytischen Domäne während des Aktiverungsprozesses genauer un-
tersucht werden.
Die Bindung zwischen der Prodomäne der Caspase-8 und FADD wurde
durch biochemische Interaktionsstudien analysiert. Darin wurde gezeigt,
dass beide Todeseffektordomänen der Prodomäne benötig werden um FADD
zu binden, da keine Bindung durch individuelle Todeseffektordomänen er-
folgte. Während der Proteinreinigung und der Interaktionsstudien wurde
wiederholt eine Oligomerisation der Prodomäne beobachtet, welche ursprüng-
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lich auf die Ausbildung von Disulfidbrücken zwischen den Prodomänen zurück-
geführt wurde. Mutation von zwei Cysteinen in der zweiten Todeseffektor-
domäne zeigte allerdings, dass dieses Phenomän nicht cysteinabhängig und
höchstwahrscheinlich biologisch nicht relevant ist.
Erste Versuche zur Expression und Reinigung eines Komplexes bestehend aus
Prodomäne und FADD für biochemische und strukturelle Charakterisierun-
gen wurden durchgeführt. Allerdings wurden diese Experimente durch eine
hohe Tendenz der Prodomäne zur Aggregation und das Vorhandensein von
grossen Fusionsdomänen an der Prodomäne und am FADD erschwert. Eine
ausführliche Diskussion im Kapitel 2.3 beschreibt verschiedene Strategien,
diese Probleme in zukünftigen Experimenten zu bewältigen.
Während die Strukturbestimmung der Prodomäne bis jetzt nicht erfolgreich
war, wurde die Struktur der katalytischen Domäne der inaktiven Procaspase-
8 mittels Kernresonanzspektroskopie bestimmt. Diese Struktur zeigt, dass
die Sekundärstrukturelemente der Procaspase-8 im Vergleich zur Caspase-8
konserviert sind. Unterschiede zwischen den beiden Strukturen sind in den
Loops um die Substratbindungsstelle und dem Linker zwischen den Unterein-
heiten der katalytischen Domäne zu finden. Biochemische und biophysikalis-
che Analysen an verschiedenen Dimerisierungs- und Prozessierungsmutan-
ten erlauben Einblicke in den strukturellen Übergang von der Procaspase-8
zur Caspase-8 und die Substatbindung an das Enzym. Diese Experimente
deuten darauf hin, dass Dimerisierung eine Umlagerung des Linkers her-
beiführt. In monomerer Procaspase-8 bedeckt ein Teil des Linkers die Stelle,
an welcher die Substratbindungstasche in der aktiven Caspase-8 gebildet
wird. Durch die Dimerisierung wird die Position des Linkers so umgelagert,
dass dessen Prozessierungsstellen in die Nähe des katalytischen Cysteins des
zweiten Caspase-8 Moleküles vom gleichen Dimer rücken und somit inter-
molekulare Spaltung innerhalb des Dimers ermöglicht wird. Dabei ist es
wichtig, dass die Caspase-8 an beiden Prozessierungsstellen gespalten wird,
um die volle Aktivität des Enzyms zu erhalten. Nach der Spaltung erfolgen
strukturelle Änderungen in den Loops an der Substratbindungsstelle und den
gespaltenen Linkerfragmenten. Dadurch wird die Substratbindungstasche
teilweise ausgebildet. Weitere Umlagerungen zur vollständigen Bildung der
Bindungstasche erfolgen während der Substratbindung.
vii
Diese Arbeit bestätigt den Einfluss der Dimerisierung auf die Aktivierung
und Aktivität der Caspase-8. Zusätzlich wird deutlich gemacht, dass pro-
teolytische Spaltung eine massgebliche Rolle im Aktivierungsprozess spielt.
Die präsentierten Ergebnisse erlauben ein tieferes Verständniss des derzeiti-
gen Aktivierungsmechanismusses der Caspase-8 und möglicherweise anderer
Caspasen.
viii ZUSAMMENFASSUNG
Acknowledgements
First of all my gratitude goes to Prof. Dr. Markus G. Grütter, who gave
me the possibility to join his group and offered me this interesting project,
which I enjoyed working on very much. Special thanks also goes to Prof.
Dr. Oliver Zerbe, who supervised me through the NMR experiments which
formed the main part of my thesis. He guided me through this for me new
field but also engaged in fruitful discussions about my work and writing. In
addition, I want to thank my committee members Prof. Dr. Michael Hen-
gartner and Dr. Elena Conti. Although they were not directly involved in
my project they always took an interest in my work and provided me with
valuable input.
Certainly I want to thank all my previous and current colleagues from
the Grütter lab (Guido Capitani, Nicole Bischoff, Beat Blattmann, Flo-
rence Bourquin, Christophe Briand, Brian Brissoni, Bice Bruppacher, Magda
Bukowska, Oliv Eidam, Sibylle Engeler, Dani Frey, Heinz Gut, Peter Gutte,
Annette Haisch, Georg Hausammann, Thomas Heitkamp, Michael Hohl, Evi
Jenny, Andi Kohl, Michaela Kramer, Mareike Kurz, Jana Lamp, Esti Lehn-
herr, Tobias Merz, Anshu Mittal, Damien Morger, Markus Müller, Dominik
Possner, Heidi Roschitzki-Voser, Diego Sanchez, Thilo Schröder, Andreas
Schweizer, Markus Seeger, Gabi Sennhauser, Christian Stirnimann, Celine
Stutz-Ducommun, Rahel Urich, Christopher Weinert and Sara Züger) and
the Zerbe group (Christina Ewald, Sowmini Kumaran, Jiri Mares, Alexey
Neumoin, Reto Walser, Svava Wetzel and Chao Zou). Unfortunately, I can-
not mention all the contributions of these people here. I just want to give a
special thank to Alexey Neumoin and Jiri Mares as well as Christophe Briand
for their introduction into the NMR and X-ray software, respectively. They
ix
x ACKNOWLEDGEMENTS
were very patient to answer all my silly questions. Further more I want to
thank Beat Blattmann. When he did not go running with me through the
woods, he was always open for questions and special plate request and was a
good company for lunch breaks. In the initial phase of my thesis he provided
me with beautiful salt crystals which finally lead me to do a successful NMR
project. Very much I enjoyed supervising Sibylle Engeler during her Master’s
thesis. By doing an excellent job in her project she substantially contributed
to the FADD project. Especially I enjoyed our fruitful discussions about
the project. Another valuable contribution to this thesis came from Mark
Monroe, Mareike Kurz and Nicole Bischoff, who were proofreading it. So if
you like reading this thesis thank them, if you do not like it, blame it on me.
Besides all the "lab rats" I also want to thank the Grütter secretaries Vreni
Diezi, Ursi Iten and Salome Rittmeyer. They did a great job in managing
the administrative site of the Grütter group as well as kept the boss in a
good mood. I also do not want to forget to thank all the service people who
ensured that life at the institute was running smoothly. The workshop guys
Jean-Claude Tomassina, Adi Schmid and Sascha Weidner always made sure
that the scientific instruments were up and running. The same holds true
for the intranet and the computer support which was maintained by the IT
service. In particular Steve Rast helped me with computer related problems.
Ausserdem möchte ich mich bei meinen Eltern bedanken. Ohne ihre Unter-
stützung hätte ich es niemals so weit gebracht. Sie haben immer an mich
geglaubt und mich jederzeit unterstützt. And finally I want to thank all the
people I could not mention here, my friends in Zurich, people from other
research groups who helped me out with discussions, reagents and introduc-
tions into certain equipment and the ASVZ with its great sport activities,
which provided an important balance to my work in the lab.
Contents
Abstract iii
Zusammenfassung v
Acknowledgements ix
List of Abbreviations xix
1 Introduction 1
1.1 Apoptosis - A programmed cell death . . . . . . . . . . . . . . 1
1.1.1 The history of a apoptosis . . . . . . . . . . . . . . . . 1
1.1.2 Apoptotic pathways - the road to death . . . . . . . . 4
1.2 Caspases - the players of the death game . . . . . . . . . . . . 7
1.2.1 Caspase activation . . . . . . . . . . . . . . . . . . . . 10
1.3 Caspase-8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.3.1 Regulation of caspase-8 . . . . . . . . . . . . . . . . . 19
1.3.2 Caspase-8 for survival . . . . . . . . . . . . . . . . . . 21
2 Binding of Procaspase-8 to FADD 23
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.2.1 Summary of previous results by Ghisleni, et al. . . . . 26
2.2.2 Pull-down experiments . . . . . . . . . . . . . . . . . . 27
2.2.3 Analysis of the biological relevance of disulfide bridge
formation in vivo . . . . . . . . . . . . . . . . . . . . . 31
2.2.4 Comparison of the caspase-8 prodomain with viral FLIP
MC159 . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
xi
xii CONTENTS
2.2.5 Complex formation between full-length FADD and the
prodomain of caspase-8 . . . . . . . . . . . . . . . . . 34
2.3 Discussion and Future Directions . . . . . . . . . . . . . . . . 37
2.4 Experimental procedures . . . . . . . . . . . . . . . . . . . . . 40
2.4.1 Protein design, expression and purification . . . . . . . 40
2.4.2 Protein stability tests . . . . . . . . . . . . . . . . . . 40
2.4.3 Pull-down experiments and Western Blot . . . . . . . 41
2.5 Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . 42
3 Structural and biochemical studies on procaspase-8 43
3.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.3.1 Procaspase-8 structure determination . . . . . . . . . . 48
3.3.2 The structure of procaspase-8 . . . . . . . . . . . . . . 50
3.3.3 Location, orientation and processing of the linker . . . 51
3.3.4 Both cleavage sites have to be processed for full activ-
ity of caspase-8 . . . . . . . . . . . . . . . . . . . . . . 54
3.3.5 Dimerization is important for caspase-8 activity . . . . 56
3.3.6 Caspase-8 processing is important in stabilizing the
active dimer . . . . . . . . . . . . . . . . . . . . . . . . 58
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.5 Experimental Procedures . . . . . . . . . . . . . . . . . . . . . 64
3.5.1 Protein design, expression and purification . . . . . . . 64
3.5.2 Assignment and structure calculation . . . . . . . . . . 65
3.5.3 Protein characterization . . . . . . . . . . . . . . . . . 66
3.6 Accession numbers . . . . . . . . . . . . . . . . . . . . . . . . 68
3.7 Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.8 Supplementary material . . . . . . . . . . . . . . . . . . . . . 69
3.8.1 Assignment and structure calculation . . . . . . . . . . 69
3.8.2 Comparison of single-chain and two-chain F468A . . . 73
4 From procaspase-8 to caspase-8 77
4.1 Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
CONTENTS xiii
4.2 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
4.3.1 Processing of procaspase-8 into active caspase-8 . . . . 81
4.3.2 Caspase-8 undergoes structural changes during pro-
cessing and during inhibitor binding . . . . . . . . . . 82
4.3.3 Determinants of the processing rate of procaspase-8 . . 86
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
4.5 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . 96
4.5.1 Protein design, expression and purification . . . . . . . 96
4.5.2 NMR experiments . . . . . . . . . . . . . . . . . . . . 96
4.5.3 Analytical ultracentrifugation . . . . . . . . . . . . . . 97
4.5.4 CD Spectroscopy . . . . . . . . . . . . . . . . . . . . . 97
4.5.5 In vitro cleavage experiments . . . . . . . . . . . . . . 97
4.6 Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . 99
Bibliography 100
A Protein sequences 119
A.1 Caspase-8 mutants . . . . . . . . . . . . . . . . . . . . . . . . 119
A.1.1 Full-length caspase-8 . . . . . . . . . . . . . . . . . . . 119
A.1.2 Prodomain of caspase-8 . . . . . . . . . . . . . . . . . 121
A.1.3 Catalytic domain of caspase-8 – single-chain constructs 123
A.1.4 Catalytic domain of caspase-8 – two-chain constructs . 125
A.2 FADD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
B Purification protocols 127
B.1 Caspase-8 prodomain . . . . . . . . . . . . . . . . . . . . . . . 127
B.2 Caspase-8 catalytic domain – single chain constructs . . . . . 129
B.3 Caspase-8 catalytic domain – two-chain constructs . . . . . . 131
B.4 FADD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
C Crystallization of Bcl-xl 135
C.1 Protein purification, crystallization and data collection . . . . 135
C.2 Structure determination . . . . . . . . . . . . . . . . . . . . . 137
xiv CONTENTS
D Curriculum vitae 139
List of Figures
1.1 Historical review of apoptosis . . . . . . . . . . . . . . . . . . 2
1.2 Morphological changes characteristic for apoptosis . . . . . . 3
1.3 Publications on topics concerning apoptosis . . . . . . . . . . 4
1.4 Apoptotic pathways . . . . . . . . . . . . . . . . . . . . . . . 6
1.5 Domain organization of mammalian caspases . . . . . . . . . 8
1.6 Structures of caspase zymogens and active caspases . . . . . . 9
1.7 Structures of death domain family domains . . . . . . . . . . 12
1.8 Activation platforms for apoptotic caspases . . . . . . . . . . 14
1.9 NALP inflammasomes for caspase activation . . . . . . . . . . 16
1.10 Caspase-8 structure and its interaction with FLIP . . . . . . . 17
2.1 Summary of pull-down results from C. Ghisleni . . . . . . . . 26
2.2 Overview of constructs used in pull-down experiments . . . . 28
2.3 Purification of proteins for pull-down experiments . . . . . . . 29
2.4 GST pull-down experiments to determine FADD/prodomain
interactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.5 Overexpression of wild-type caspase-8 and cysteine mutants
in Cos cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.6 Comparison of the procaspase-8 prodomain with viral FLIP
MC159 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.7 Overview of available caspase-8 prodomain constructs . . . . 35
2.8 Purification of coexpressed FADD and DED12 . . . . . . . . . 36
3.1 Dynamic analysis and solution structure of procaspase-8 . . . 49
3.2 Comparison of procaspase-8 with active caspase-8, respective
linker rearrangements and substrate binding . . . . . . . . . . 52
xv
xvi LIST OF FIGURES
3.3 Definition of the position of the linker by NOE-derived restrains 53
3.4 Overview of caspase-8 constructs . . . . . . . . . . . . . . . . 55
3.5 Structural features important for dimerization of caspase-8 . . 57
3.6 Structure and sequence comparison of procaspase-8 with other
caspases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.7 [15N, 1H]-HSQC spectra of inactive monomeric procaspase-8
and active dimeric caspase-8 . . . . . . . . . . . . . . . . . . . 71
3.8 Restraints used in the Structure Calculation . . . . . . . . . . 72
3.9 [15N, 1H]-HSQC spectra of unprocessed F468A and proteolyt-
ically cleaved αβ-F468A . . . . . . . . . . . . . . . . . . . . . 75
3.10 Expansion of the [15N, 1H]-HSQC spectrum of PC8, unpro-
cessed F468A and proteolytically cleaved αβ-F468A . . . . . 76
4.1 Processing of procaspase-8 into caspase-8 . . . . . . . . . . . . 82
4.2 Comparison of [15N, 1H]-TROSY spectra of procaspase-8 (C285A)
at the beginning and the end of cleavage reaction . . . . . . . 83
4.3 Comparison of procaspase-8 with caspase-8 in the absence and
presence of the tetrapeptidic DEVD inhibitor. . . . . . . . . . 84
4.4 Overview of caspase-8 mutants used in this study . . . . . . . 86
4.5 Processing of various procaspase-8 mutants by caspase-8 . . . 88
4.6 Comparison of different caspase activation states . . . . . . . 93
4.7 Schematic drawing of the caspase-8 activation mechanism . . 94
C.1 Purification of Bcl-xl . . . . . . . . . . . . . . . . . . . . . . . 136
C.2 Crystal growth at 4◦C and 20◦C . . . . . . . . . . . . . . . . 136
C.3 Bcl-xl structure . . . . . . . . . . . . . . . . . . . . . . . . . . 138
List of Tables
1.1 Overview of mammalian caspases and their substrate specificity 7
3.1 Biochemical analyses of caspase-8 mutants . . . . . . . . . . . 56
3.2 Structural statistics . . . . . . . . . . . . . . . . . . . . . . . . 73
4.1 Analytical ultracentrifugation of caspase-8 and caspase-8 mu-
tants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
C.1 X-ray data collection and refinement statistics . . . . . . . . . 137
xvii
xviii LIST OF TABLES
xix
xx LIST OF ABBREVIATIONS
List of Abbreviations
Proteins, Complexes and Diseases
Abbreviation Full Meaning
ALPS Autoimmune lymphoproliferative syndrome
Apaf1 Apoptosis protease-activating factor 1
ASC Apoptosis associated speck-like protein containing a CARD
Bak Bcl-2 antagonist/killer
Bax Bcl-2 associated protein X
Bcl-2 B cell leukemia 2
Bcl-xl B cell leukemia XL
BH3 Bcl-2-homology domain 3
CARD Caspase-associated recruitment domain
CED C.elegans cell death
DD Death domain
DDAA Double mutation of caspase-8: D374A, D384A
DED Death effector domain
DISC Death inducing signaling complex
ER Endoplasmatic reticulum
FADD Fas-associated death domain
FLIP Flice (= synonym for caspase-8) like inhibitory protein
IAP Inhibitor of apoptosis
ICE Interleukin-1β-converting enzyme
LRR Leucine-rich repeats
NLR NOD-like receptor
PIDD p53-induced protein with a DD
PC8 Procaspase-8
RAIDD RIP-associated ICH-1/CED-3-homologous protein with DD
RIP Receptor-interacting protein
TLR Toll-like receptor
xxi
Reagents and Materials
Abbreviation Full Meaning
AMC 7-amino-4-methylcoumarin
ATP Adenosintriphosphat
cmk chloro-methylketone
DDT Dithioerithiol
EDTA Ethylenediaminetetraacetic acid
GdHCl Guanidine hydrochloride
LDAO Lauryldimethylamine-oxide
MES 2-(N-morpholino)ethanesulfonic acid
PBS Phosphate-buffered saline
TCEP Tris(2-carboxyethyl)phosphine
TBS Tris-buffered saline
TBST TBS with 0.2% Tween-20
Methods and programs
Abbreviation Full Meaning
BMRB Biological Magnetic Resonance Bank
DAPI 4,6-Diamidino-2-phenylindole
HSQC Heteronuclear single quantum coherence
hNOE Heteronuclear Overhauser effect
NOESY Nuclear Overhauser enhancement spectroscopy
PDB Protein Data Bank
TOCSY Total correlated spectroscopy
TROSY Transverse relaxation optimized spectroscopy
xxii LIST OF ABBREVIATIONS
Chapter 1
Introduction
1.1 Apoptosis - A programmed cell death
1.1.1 The history of a apoptosis
Apoptosis is a cell death program that is present in all mammalian and some
plant cells. Several bacteria and yeast also have such a process genetically
encoded [1]. The term was defined in 1972 by Kerr at al. [2]. However, it
was used in the literature almost 2000 years ago by Hippocrates of Cos to
describe a physiological form of tissue death observed at fractures that were
covered by bandages [3]. The word ’apoptosis’ is derived from the Greek
roots ’apo’ and ’ptosis’, which together mean ’falling apart’.
Although the term apoptosis cannot be found in the literature again until
1972, fundamental research in the area was being performed in the mid 19th
century (Figure 1.1, reviewed in [4]). In 1842, Karl Vogt first described cell
death in the normal development of metamorphic toads [5]. Two decades
later, in 1860, Rudolph Virchow distinguished between two forms of cell
death - necrosis and necrobiosis - with the later describing morphological
changes later defined to be characteristic for apoptosis [6]. A few years later,
Walther Flemming, for the first time suggested that intracellular chemical
changes rather than external mechanical forces were the cause of this type
of cell death [7]. He was also the first one to describe chromatin disinte-
gration, a hallmark of the apoptotic cellular death process. When in 1951
Glucksmann prepared a list of all types of cell death known to date, many
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Figure 1.1: Historical review of apoptosis.
A more detailed description of the historical events in the discovery and
definition of apoptosis is summarized in a review by Diamentis, et.al [4].
morphological changes such as chromatin condensation and nuclei fragmen-
tation were included on that list [8].
Finally, in 1972 Kerr et al. defined the term apoptosis as a mechanism for
the disposal of unwanted cells during embryonic development as well as nor-
mal tissue homeostasis throughout life [2]. In his fundamental publication
he describes most of the morphological changes nowadays widely accepted to
be linked to apoptotic cell death (Figure 1.2, [10]): In the early stage dying
cells detach themselves from surrounding cells and round up, which can be
easily observed under a normal light microscope. Next, small protrusions
from the plasma membrane appear. This phenomenon is called membrane
blebbing. Finally the whole cell condenses into ’apoptotic bodies’, which will
be engulfed and digested by macrophages. On the intracellular level most
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Figure 1.2: Morphological changes characteristic for apoptosis
A) Electron microscopy image of an apoptotic cell detached from surround-
ing cells. Extensive membrane blebbing is evident.
B) Chromatin condensation (arrow heads) and fragmentation (arrows) visu-
alized by DAPI staining (adapted from Zoli et al. [9]).
C) DNA laddering on an agarose gel (adapted from: www.research.kobe-
u.ac.jp/brce-mikitani/english.html). Following two marker lanes chromoso-
mal DNA at increasing levels of fragmentation is visible.
C) Schematic drawing of the engulfment of an apoptotic cell (left) by a
macrophage (right) (adapted from the U.S. National Library of Medicine).
changes are restricted to the nucleus. Chromosomal DNA condensates and is
digested into smaller fragments. The condensed nucleus finally disintegrates
into smaller particles. In contrast to the nucleus, which is effected early dur-
ing apoptosis most other organelles seem to remain intact for at least some
time. In some cases swelling or condensation of mitochondria and membrane
permeabilization was described [10]. During the whole process of apoptosis
the cytosolic contents of the cell is surrounded by the cellular membrane.
This prevents release of the intracellular components and keeps an immune
response from occurring. [11].
The introduction of modern DNA techniques and genetic model organisms
such as Caenorhabditis elegans and Drosophila melanogaster in the early
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Figure 1.3: Publications on topics concerning apoptosis
Listed are all PubMed publications with the term ’apoptosis’ appearing in
either the title or abstract. The inset zooms in on the publications of the
early years with a larger scale on the publications per year axis.
1970th greatly advanced our understanding of apoptosis. In 1977, Sulston
and Horvitz made the exciting discovery that during normal development
in the nematode C.elegans, exactly 131 out of 1090 somatic cells undergo
programmed cell death [12]. Further research on the worm lead to the dis-
covery of the first apoptotic gene, ced-3 in 1982 [13]. Many more pro- and
antiapoptotic genes followed. Researchers all over the world started to in-
vestigate various aspects of apoptosis as evident by a rapidly increasing rate
of publications on this topic (Figure 1.3).
1.1.2 Apoptotic pathways - the road to death
To date, two different apoptotic pathways have been distinguished - extrinsic
and intrinsic - depending on the origin of the apoptotic stimulus. The extrin-
sic pathway is initiated by binding of an extracellular ligand or antagonist
to an extracellular part of a transmembrane death receptor. A well studied
example is the Fas mediated pathway. Upon an apoptotic stimulus the Fas
ligand binds to the Fas receptor. This leads to the oligomerization of the
receptor. Signal transduction from the Fas receptor to downstream proteins
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is mediated by the adapter protein FADD. This FADD is responsible for the
recruitment of the caspases-8 and -10 to a macromolecular complex which is
termed the death inducing signaling complex (DISC). After activation at the
complex, the caspases are released and process downstream targets, such as
caspase-3 and -7, which in turn cleave further proteins, finally leading to self
destruction of the cell. A more detailed description of the molecular inter-
actions at the DISC and the activation of the caspases are given in chapter
1.2.1.
Apoptotic cell death can also be induced by internal stimuli such as cyto-
toxic stress or DNA damage [14]. As a response diverse proteins belonging to
the BH3-only proteins are activated. If this activation overcomes a certain
threshold it can compensate the inhibitory effects executed by antiapop-
totic proteins of the Bcl-2 family. This results in the formation of Bax/Bak
oligomers within the outer membrane of mitochondria and subsequent re-
lease of cytochrome c from the mitochondria [15]. Together with Apaf1 and
caspase-9 and the cofactor ATP, cytochrome c forms the apoptosome which
activates caspase-9 [16,17]. After activation, caspase-9 further cleaves down-
stream caspases -3 and -7, which subsequently lead to the execution of the
cell [18].
Apoptosis can also be initiated by a combination of the two pathways de-
scribed above. Whereas so called type I cells display the extrinsic pathway,
some crosstalk between the extrinsic and the intrinsic pathway exists in type
II cells. There, the formation of the DISC is reduced as compared with type
I cells, which results in lower levels of active caspase-8. In order to achieve
sufficient apoptosis an amplification of the signal is needed. This is achieved
by cleavage of the Bcl-2 family protein Bid by caspase-8 to generate tBid [19].
tBid locates to the mitochondria and induces release of cytochrome c, which
leads to activation of the intrinsic cell death pathway [20,21].
Induction of the intrinsic pathway can also be induced by the initiator
caspase-2, which was shown to be able to promote cytochrome c release
from mitochondria [22,23]. However, how this happens is not yet under-
stood. In general, programmed cell death via caspase mediated cascades
is a highly complex mechanism. We most likely only know about a small
fraction of what is really going on in dying cells. However, a complete or at
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Figure 1.4: Apoptotic pathways.
The extrinsic Fas mediated pathway is displayed on the left side, the intrinsic
pathway is shown on the right. Both pathways lead to activation of caspase-3
and -7.
least better understanding of the involved pathways is essential to fight many
wide spread diseases. Already in 1973 Danielevicius suggested a direct link
between improper apoptosis and the development of cancer [24]. Nowadays,
it is a well known fact, that inappropriate cell accumulation is involved in
many different types of cancer as well as autoimmune diseases [25–29]. In
contrast, excessive cell death has been linked to stroke, Alzheimer’s and
Parkinson’s disease [30]. Furthermore, many viruses directly influence the
apoptotic pathways of their host, which leads to infectious diseases such as
AIDS [1,31].
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Group Cellular Group Substrate
(Subfamily) function members specificity
Group I Inflammatory Caspase-1 WEHD
(ICE) mediators Caspase-4 (W/L)EHD
Caspase-5 WEHD
Caspsae-11
Caspase-12 WEHD
Caspase-13
Caspase-14 WEHD
Group II Apoptotic Caspase-2 DEHD
(CED3) initiators Caspase-8 IETD
Caspase-9 (L/V)EXD
Caspase-10 (L/V)EXD
Group III Apoptotic Caspase-3 DEHD
executioner Caspase-6 VEHD
Caspase-7 DEVD
Table 1.1: Overview of mammalian caspases and their substrate specificity
1.2 Caspases - the players of the death game
Caspases function in key positions along the apoptotic pathway. These en-
zymes form a class of endoproteases with a cysteine in the active site and
have a specificity for aspartate in their substrates. The first caspase identified
was ICE/caspase-1, which is involved in the proteolytic maturation of pro-
interleukin-1β [32,33]. Fourteen different mammalian caspases are known to
date. Caspases cleave a great variety of substrates, among them transcrip-
tional and translational regulators, structure proteins and many kinases. The
online database CASBAH (www.casbah.ie) lists all natural known caspase
substrates [34].
Caspases can be grouped by how they function. They take part in inflam-
matory or apoptotic processes (Table 1.1). However, some take part in both
processes, and therefore are not easily categorized. Apoptotic caspases can
be further divided into apical initiator caspases and downstream execution-
ers. In addition to their different positions within the apoptotic cascade
initiators and executioners also differ in their domain architecture (Figure
1.5). They all contain a catalytic domain with a large (∼20 kDa) and a
small (∼10 kDa) subunit, termed p20 or α and p10 or β. These units are
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Figure 1.5: Domain organization of mammalian caspases. The position of
the P1 aspartates are indicated by arrows and residue numbers. Proteolytic
cleavage occurs after the assigned residues.
connected by a linker. The initiator caspases contain additional hexa-helical
domains at their N-termini. These so called prodomains contain either one
CARD or tandem DED domains and are linked to the catalytic domain by
a flexible linker region. The executioner caspases contain only short, if any,
prodomains.
Structural information on the catalytic domains of caspases is available (Fig-
ure 1.6). Executioner caspases and active initiator caspases are present in the
cell as dimers, whereas initiator zymogens appear to be monomeric. Most
of the structures solved today show dimeric active caspases with a variety
of different small molecule inhibitors bound. All of these structures share
the same overall fold: Each catalytic unit contains a six-stranded β-sheet
with five parallel and one antiparallel strand. Within the dimer the six-
stranded β-sheet is expanded to a twelve-stranded sheet with the antiparallel
strands positioned at the dimerization interface. The individual protomers
are thereby arranged in a head-to-tail fashion. The central β-sheet of each
protomer is surrounded by five α helices, three and two flanking opposite
sites of the β-sheet.
Protruding from this core are flexible loops: L1-L4 (Figure 1.6 E). They are
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Figure 1.6: Structures of caspase zymogens (blue) and active caspases (red).
Inhibitors are indicated as yellow sticks.
A) X-ray structure of the Drosophila melanogaster initiator procaspase
Dronc (PDB code 2FP3).
B) First X-ray structure of a caspase - caspase-1 (PDB code 1IBC). Although
the PDB file contains only a monomer of caspase-1 it is known to be a dimer.
C) X-ray structures of dimeric inactive procaspase-7 (blue, PDB code 1K88)
and active caspase-7 (red, PDB code 1K86).
D) Structure of caspase-9 (PDB code 1JXQ). The inhibitor (yellow) is bound
to only one monomer. In the second protomer is in a conformation not suit-
able for substrate binding.
E) Superposition of the active site conformation of different caspases. The
individual enzymes are colored as followed: Caspase-1 = yellow, caspase-2
= green, caspase-3 = blau, caspase-7 = orange, caspase-8 = red, caspase-9
= cyan. The positions of the catalytic loops (L1-L4) are indicated.
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all located on one side of the β-sheet and are involved in forming the substrate
binding pocket. L2 contains the active site cysteine (C285 in caspase-1 num-
bering), which is part of a highly conserved amino acid sequence: QACxG.
L1 and L3 display a similar length and position in all caspase structures
solved to date. L2 and L4 are less conserved. Together the loops form
the substrate binding pocket, which can accommodate the typical caspase
recognition sequence: XP4EP3XP2DP1. P1, which represents the aspartate
directly adjacent to the catalytic cleavage site and P3 are very invariant in
substrates of all caspases. This is reflected in a high conservation of the cor-
responding S1 and S3 substrate binding pockets of the active enzyme, which
are almost identical in shape in all caspase structures. The S1 pocket is lined
by two conserved arginines positioned on L1 and L3 as well as a glutamine
at L2 resulting in a highly basic pocket where aspartate can bind [35]. The
S2 and especially S4 binding regions are less conserved and are responsible
for substrate specificity. Depending on this substrate specificity, caspases
can be divided into three different groups: Caspases-1, -4, and -5 possess
a relatively wide S4 subsite and therefore share a preference for bulky hy-
drophobic residues at the P4 position. They belong to group I. Group II
comprises caspases-8, -9, and -10. They prefer branched aliphatic side chains
at P4 position. Caspases belonging to group III encompass caspases-3 and
-7. This group has a requirement for aspartic acid in P4 due to a very narrow
and positively charged S4 binding pocket.
1.2.1 Caspase activation
In order to bind and process their substrates, caspases need to be activated
first. Thereby, executioner and initiator caspases apply different mechanism.
Dimeric executioner caspases are activated by proteolytic processing at their
intersubunit linker, resulting in the formation of L2 and L2’ fragments, which
are linked to the p20 and p10 subunits, respectively. Furthermore, this re-
sults in the rearrangement of the catalytic loops. Especially L2 and L2’
undergo major structural changes. After cleavage L2 translocates towards
the other protomer where it interacts with the corresponding L2’. These re-
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arrangements are only possible after catalytic processing of the linker region.
In contrast, it was shown that catalytic processing of initiator caspases is not
sufficient for their activation [36]. Rather dimerization seems to be the stimu-
lus for apical caspase activity. This was described first by the ’close proximity
model’ in 1998 and later on refined to the ’proximity-induced dimerization
model’ [37,38]. These models state that initiator caspases are activated when
brought in close proximity to each other and subsequent homodimerization is
enforced. This is achieved by recruitment of the enzymes to macromolecular
activation platforms. Several of these complexes have been described over
the years: The death inducing signaling complex - DISC, the apoptosome,
the inflammasome and the PIDDosome (reviewed in [39–43]). They activate
apoptotic as well as inflammatory caspases.
Death domains
An important feature for the activation of caspases on the activation com-
plexes are homotypic interactions between domains belonging to the class
of death domains (Figure 1.7, reviewed in [44,45]). Members of this class
comprise the death domain (DD), the death effector domain (DED), the
caspase recruitment domain (CARD) and the pyrin domain (PYD). They
all share a common fold of a six α helices arranged in a Greek key topology.
An exception is the pyrin PYD domain of NALP1 where the third α helix
is disordered [46]. Interactions between the individual death domains of dif-
ferent proteins have so far only been observed between members of the same
subfamily of death domains, i.e. CARD with CARD, DED with DED, etc
(Figure 1.7 C, E). These interactions form the basis of the assembly of various
complexes important for caspase as well as kinase activation [44,45]. Thus,
death domains are important for proximity induced dimerization, proteolytic
processing or phosphorylation of their adjacent domains.
The death inducing signaling complex - DISC
The extrinsic apoptotic pathway is initiated by binding of an extracellular
Fas ligand to a transmembrane Fas receptor, followed by oligomerization of
12 CHAPTER 1. INTRODUCTION
Figure 1.7: Structures of death domain family domains. Solution and X-ray
structures of A) NALP1 PYD (1PN5), B) Fas DD (1DDF), C) Complex of
the Pelle/Tube DD from Drosophila melanogaster (1D2Z), D) FADD with
DED and DD (2GF5), E) tandem DD viral FLIP MC159(2BBR) and F)
Apaf-1/caspase-2 CARD complex (3YGS). The Figure was prepared using
PyMol (DeLano, Scientific). The helices of each death domain are colored in
rainbow from blue at the N-terminus to red at the C-terminus. NALP1 PYD
and the DDs of Fas, Tube and FADD are displayed in the same approximate
orientation. FADD DED was superimposed with the first DED of vFLIP.
the receptor (Figure 1.8 A). Signal transduction from the Fas receptor to the
downstream proteins is mediated by the adapter molecule FADD [45]. FADD
is a two domain protein with an N-terminal DED and a C-terminal DD.
The DD binds homotypically to the intracellular DD of Fas via electrostatic
interactions. The structures of the individual DDs of both proteins as well
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as the complex between them were solved (Figures 1.7B, 1.8A, [47–49]).
Upon complex formation the FADD DD undergoes only minor structural
changes whereas major rearrangements in the DD of Fas occur [49]. The
sixth helix of the Fas DD shifts for about 40 Å which results in the formation
of an extended helix comprising helices five and six. This opening exposes a
hydrophobic patch where FADD binds. Furthermore, the authors stated that
this elongated helix also undergoes oligomerization with proximal Fas/FADD
complexes, resulting in further oligomerization of the DISC [49].
Via its N-terminal DED FADD is able to recruit procaspase-8 or -10 to the
DISC. Both proteases contain tandem DEDs at their N-terminal prodomain,
which are involved in the interaction with the FADD DED. As a result
the caspases autoprocess themselves at their intersubunit linker followed by
another cleavage event between the prodomain and the catalytic domain.
The active dimeric caspase is released in the cytosol where it initiates the
apoptotic catalytic cascade.
The individual domains of the different DISC proteins have already been
characterized. However, their stoichiometry remains enigmatic. Efforts to
isolate the DISC from cells or reconstitute it in vitro have been unsuccessful
so far. This is most likely due to self aggregation of the proteins. This
aggregation phenomenon might play a role in in vivo DISC formation, but
that still remains to be investigated. At the moment it is unknown if the
DISC exists in a single conformation. Different oligomerization states might
exist.
Apoptosome
Structurally better defined than the DISC, is the composition of the apop-
tosome (Figure 1.8 B, [16,50]). The apoptosome is required for caspase-9
activation and is composed of cytochrome c, the cofactor ATP, the adapter
protein Apaf-1 and caspase-9 [51]. Apaf-1 is a multidomain protein contain-
ing an N-terminal CARD, a central nucleotide binding and oligomerization
domain and a C-terminal WD40 domain with 13 WD40 repeats. Without
an apoptotic stimulus it exists in an inactive conformation with the individ-
ual domains accommodating a compact structure [52]. Upon the binding of
14 CHAPTER 1. INTRODUCTION
Figure 1.8: Activation platforms for apoptotic caspases
On the left hand side schematic drawings of the activation complexes are
shown. Available structures of the whole complex or parts of it are shown
on the right side. The applied color coding on the scheme and the structures
indicate identical elements. The molecule structures in A) and C) were pre-
pared using PyMol (DeLano, Scientific).
A) Death inducing signaling complex - DISC - with the corresponding X-ray
structure of the Fas-DD/FADD-DED complex (PDB code 3EZQ)
B) Apoptosome. The right panel shows an EM structure at 12.8Å resolution
at two different views rotated by 180◦. The structural figures were adapted
from Yu et al. [50].
C) PIDDosome. On the right hand side two different orientations of the
PIDD-DD/RAIDD-DD complex are displayed (PDB code 2OF5). The sec-
ond structure is rotated by 90◦ towards the viewer. The complex contains
seven RAIDD-DDs and five PIDD-DDs.
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ATP and cytochrome c Apaf-1 extends to an elongated structure, exposing
the previously buried caspase-9 binding interface on its CARD. In this open
conformation Apaf-1 assembles to a seven-wheeled macromolecular complex
with a 1:1 stoichiometry of all involved proteins (Figure 1.8 B, [16,50]). The
seven CARDs of Apaf-1 form a central ring with the caspase-9 binding site
exposed. The other domains of Apaf-1 protrude from this ring. Cytochrome
c was found to be bound between two β-propellers formed by seven and six
WD40 repeats of the WD40 domain, respectively.
Caspase-9 is recruited to this complex by CARD/CARD interactions be-
tween its own prodomain and the N-terminal domain of Apaf-1 [53]. Binding
of caspase-9 to the apoptosome results in dimerization. Autoprocessing is not
required for the activation of caspase-9 [54,55]. Dimerization without cleav-
age is sufficient for full caspase-9 activation. In its dimeric form caspase-9
remains attached to the complex, while processing its targets. This observa-
tion supports the induced proximity model [37,38].
PIDDosome
Another activation platform is the PIDDosome, which is responsible for
caspase-2 activation (Figure 1.8 C, [56]). This complex contains PIDD, the
adapter protein RAIDD and caspase-2. Formation of it seems to be induced
by an intracellular increase of PIDD [57], a protein not only involved in ini-
tiation of apoptosis but also in activation of NF-κB [58]. PIDD contains
an N-terminal LRR domain, two ZU-5 domains and a C-terminal DD. It is
often autoprocessed between the two ZU-5 domains and between the second
ZU-5 and the DD and the site of processing decides between PIDDs pro-
and anti-apoptotic functions [59]. Processing after the second ZU-5 results
in separation of the DD from the rest of the protein. This single DD can
then bind to the C-terminal DD of the adapter protein RAIDD. The re-
sulting complex reveals an unusual stoichiometry of seven RAIDDs and five
PIDD molecules (Figure 1.8 C).
Besides the DD RAIDD also contains an N-terminal CARD which recruits
caspase-2 to the complex via homotypic CARD/CARD interactions. Bound
to this complex caspase-2 is activated and can induce the intracellular apop-
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Figure 1.9: NALP inflammasomes for caspase activation.
Shown are two examples of inflammasomes containing NALP proteins. Other
inflammasomes containing different NOD-like receptors are known.
totic pathway in response to intracellular stress. Therefore, it acts upstream
of the mitochondria by inducing Bid cleavage, Bax translocation to the mi-
tochondria and subsequent cytochrome c release [22,23].
The NALP inflammasomes
Upon tissue injury or infection, cellular pathways are activated which lead to
inflammation. These pathways can be induced by the inflammatory caspases
-1, -4 and -5. As their apoptotic counterparts, the initiator caspases -1 and
-5 have been found to be recruited to macromolecular activation complexes,
termed inflammasomes (Figure 1.9, reviewed in [41,42]). Different types of
inflammasomes have been identified so far. They all contain proteins be-
longing to the family of NOD-like receptors (NLRs), such as the NALPs,
IPAF and NAIPs [60]. NALP1, 2 and 3 have been shown to be involved in
caspase-1 activation. Via their N-terminal PYD they bind the adapter pro-
tein ASC through homotypic domain interactions. In addition to PYD ASC
also harbors a CARD domain which is involved in caspase-1 recruitment
(Figure 1.9). The NALP3 inflammasome can bind an additional caspase-1
molecule via the CARD of the adapter protein cardinal (Figure 1.9 B). Fur-
thermore, caspase-1 can be activated by binding to IPAF forming the IPAF
inflammasome [61].
Despite the discovery of multiple pathways for caspase-1 activation no acti-
vation platform for caspase-4 is known. Caspase-5 can be activated by the
NALP1 inflammasome by a mechanism different from caspase-1. It binds di-
rectly via its CARD to the C-terminal CARD of NALP1 (Figure 1.9 A, [62]).
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Figure 1.10: Caspase-8 structure and its interaction with FLIP
A) Structure of dimeric active caspase-8 (red, PDB code 1QDU) with a
DEVD tetrapeptide (yellow) bound in the active site.
B) Heterodimer of the catalytic domains of procaspase-8 (red) and FLIP
(blue, PDB code 3H11)
C) Structure of FLIP (blue, PDB code 3H13)
1.3 Caspase-8
Caspase-8 is the most apical caspase of the extrinsic apoptotic pathway and
therefore belongs to the initiator caspases. It contains a prodomain of 180
amino acids, comprising two death effector domains (DED) followed by a
40 amino acid linker connecting the prodomain with the catalytic domain.
The latter contains ∼260 amino acids and can be divided into a large (p18
or α) and a small (p11 or β) subunit. These two subunit are linked by a
40 amino acid linker, which contains the two caspase-8 cleavage recognition
motifs, VETD and LEMD. Processing at both sites results in separation of
the two subunits and removal of a ten amino acid fragment during caspase-8
activation at the DISC and can occur intramolecularly as well as intermolec-
ularly [63]. Following the subunit separation is a second cleavage step which
releases the dimeric active caspase from the DISC-bound prodomain [64].
The structure of active caspase-8 with a bound inhibitor was first described
in 1999 by two different groups (Figure 1.10 [65,66]). Both structures show
dimeric caspase-8. However, in solution active caspase-8 exists in a monomer/
dimer equilibrium with a dissociation constant of 50 µM [67]. This value is
decreased by 10-fold upon inhibitor binding, indicating that addition of the
inhibitor shifts the monomer/dimer equilibrium towards the dimer species.
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The interface of this dimer is formed by hydrophilic and hydrophobic inter-
actions and multiple hydrogen bonds [65,66]. In addition, the dimer seems
to be stabilized by translocation of the cleaved linker fragments, which are
termed L2 and L2’ for fragments belonging to the α and β subunit, respec-
tively. Thereby, L2 forms contacts with L2’ of the other protomer and this
interaction is thought to enhance dimerization stability [66].
Overall, caspase-8 represents the typical caspase fold described in Chapter
1.2 (Figure 1.10 A). The secondary structure elements of caspase-8 align well
(rmsd ∼1Å) with the secondary structure elements of other caspase struc-
tures. Differences to other caspase structures are restricted to the loops
which form the active site pocket and define the substrate specificity of
caspase-8 (Figure 1.6 E). Loop1 is longer than in other observed caspases. It
contains a short α helix, which seems to be unique to caspase-8. In caspase-
8, loop1 is involved in substrate binding by forming direct contacts to the P1
aspartate and the P3 glutamic acid of a bound substrate [65]. Loop3 forms
one side of the S4 pocket and therefore defines the substrate specificity at P4.
Together the loops form a cleft on the surface, where natural and synthetic
substrates or inhibitors can bind.
Caspase-8 was crystallized with different inhibitors, covalently bound to the
active site cysteine [65,66,68–71]. All these structures reveal a positively
charged S1 binding pocket, which is lined by several conserved residues:
Arg413, Arg260 and Gln358 [66]. These residues form salt bridges with the
P1 aspartate. Furthermore, the P1 α-carbonyl forms a hydrogen bond to the
catalytically important His317. Besides the absolute requirement for aspartic
acid in the P1 position, the P3 position in caspase-8 is also well defined. All of
the solved structures accommodate a glutamic acid in the P3 position of the
inhibitors. This residue forms hydrogen bonds to the conserved Arg413 and
to Arg258 in loop1. The S4 pocket is formed by the bulky aromatic residues
Trp420 and Tyr412, which explains the preference for small hydrophobic
residues in the P4 position of the caspase-8 substrates [66]. Trp420 is the
only tryptophan present in caspase-8. Besides forming the S4 pocket it also
lines the S2 pocket [68]. Although it is located at the substrate binding site
Trp420 is not buried by the inhibitor. The solvent accessible surface of it
with and without inhibitor was calculated to be identical [67]. Thus, Trp420
1.3. CASPASE-8 19
has been used previously by several research groups to monitor structural
changes in the active sites of caspase-8 during different states of activation
using fluorescence changes [36,67].
It is currently unknown exactly how caspase-8 binds to the DISC since struc-
tural information on the prodomain of caspase-8 is still missing. However,
the structure of the viral caspase-8 homologue FLIP MC159 has been solved
and gives us some clues about the binding (Figure 1.7 C, [72]. As caspase-
8 MC159 contains two DEDs responsible for protein-protein interactions
with FADD. High sequence similarity between the caspase-8 prodomain and
MC159 suggest a similar structure for caspase-8. MC159 contains two DEDs
tightly packed to each other rather than separate domains connected by a
flexible linker. Each of the two DEDs contains a hydrophobic patch at he-
lices 2 and 5. This patch of DED1 is buried by helices 1 and 4 of DED2.
In contrast, the hydrophobic region on helices 2 and 5 of DED2 is surface
exposed. Recent mutagenesis studies imply an involvement of this region in
binding to FADD [72]. In addition residues within helices 1 and 4 of FADD
have been suggested to be involved in caspase-8 binding. Together, these
observations imply an analogous binding of FADD to the DED2 of caspase-8
as is observed between DED1 and 2 of MC159 [73]. However, the accurate
assembly of the two proteins into a complex has to be verified structurally.
1.3.1 Regulation of caspase-8
Caspase-8 regulation by FLIP
Caspase-8 represents the most apical caspase of the extrinsic apoptotic path-
ways. Since it is positioned at the beginning of a signaling cascade it is im-
portant that its activation and function is well regulated. In addition to Fas,
FADD, caspase-8 and -10, and a caspase-8 homologue, called FLIP is also
found in the DISC (Figure 1.8 A, [74,75]). This protein seems to be involved
in direct caspase-8 regulation. Cellular FLIP is expressed in three different
forms: a long splice variant c-FLIPL and shorter versions c-FLIPS and c-
FLIPR [76,77]. The short splice variants are similar to the DED containing
prodomain of caspase-8, whereas the long version contains an additional do-
main homologous to caspase-8 but inactive. Besides the cellular FLIPs, a
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viral FLIP v-FLIP exists, which resembles the short cellular FLIPs in length.
All splice variants compete with caspase-8 and -10 for binding to the DISC.
The short splice variants were found to be inhibitors of caspase-8 by com-
peting for the binding sites on FADD, whereas c-FLIPL can function either
pro- or anti-apoptotic depending on its concentration in the cell [75,78].
The catalytic domain of caspase-8 and the corresponding sequence of c-
FLIPL share 28% sequence identity and 44% sequence similarity. The struc-
ture of the domains are highly similar (Figure 1.10, [79]. The secondary
structure elements of the two proteins superimpose well with an rmsd of 1.8
Å. Structural differences are located in the loops which form the active site in
caspase-8 but do not so in c-FLIPL. Apparently, c-FLIPL regulates caspase-
8 activity by formation of a heterodimer with caspase-8 [79]. Interestingly,
c-FLIPL also dimerizes with inactive procaspase-8, which is not able to ho-
modimerize with itself. This indicates a higher affinity of procaspase-8 for
c-FLIPL than for itself. In the hetrodimeric complex, procaspase-8 is found
to be in the active conformation. At this stage it is able to process different
substrates such as other procaspase-8 molecules and its dimerization partner
c-FLIPL. Catalytic processing of c-FLIPL in this heterodimer results in in-
creased catalytic activity of the complexed caspase-8, independent of its own
processing state [79]. Thus c-FLIPL is a potent enhancer of apoptotic activ-
ity when bound to the DISC. However, it is currently unclear whether the
heterodimer is released from the DISC into the cytosol. c-FLIPL-dependent
activation of caspase-8 might be locally restricted to the DISC environment.
Phosphorylation of caspase-8
Phosphorylation and dephosphorylation has been shown to be a powerful tool
to regulate protein expression, binding or function. An effect on apoptosis
has been previously shown on caspase-9, whose activity was inhibited by
phosphorylation [80–82]. Caspase-8 also undergoes phosphorylation in the
presence of active Src kinase [83]. This kinase was found to be up-regulated in
different colon cancers, together with an increase of phosphorylated caspase-
8 in infected cells [83,84]. The phosphorylation site on caspase-8 was mapped
to Tyr380, which is located in the linker region between the two subunits
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and is conserved in other mammalian organisms [83]. In vivo studies by
Cursi et al. revealed that phosphorylation at Tyr380 results in impaired
receptor mediated apoptosis. Since, during catalytic processing a ten amino
acid fragment containing Tyr380 is cleaved off, regulation of apoptosis by
caspase-8 phosphorylation is most likely linked to some inhibitory effects on
caspase-8 activation. In fact, it was suggested that modification of Tyr380
interferes with processing and thus activation of monomeric procaspase-8 to
dimeric caspase-8 [83].
1.3.2 Caspase-8 for survival
Besides its role in cell execution caspase-8 is also involved in several path-
ways important for cell survival, such as embryonic development, monocyte
differentiation, and T cell activation as well as innate immunity (summa-
rized in [85]). Most of these pro-survival functions of caspase-8 are tightly
linked to the NF-κB pathway. By cleaving RIP1, an antagonist of NF-κB,
caspase-8 plays an important role in macrophage differentiation [86,87]. No
macrophage differentiation was observed in caspase-8 deficient bone marrow
precursor cells or upon addition of caspase inhibitor to normal cells [86,88].
Furthermore, specific caspase-8 inhibitors have also been found to decrease
T cell activation and proliferation [26], suggesting a crucial role of caspase-8
in this process. Defects in T cell regulation are directly linked with dis-
eases such as the autoimmune lymphoproliferative syndrome (ALPS)and a
homozygous mutation (R248W) in caspase-8 has been identified in patients
with this disease [25].
Caspase-8 dependent activation of NF-κB is not only important for T cell
proliferation but also plays an important role in innate immunity. This de-
fense mechanism against microbial infections is mediated by Toll-like recep-
tors (TLR). For example, TLR4 activation results in apoptosis of dendritic
cells and macrophages upon bacterial infections [89,90]. Recent studies have
revealed the presence of small quantities of functional but uncleaved caspase-
8 during NF-κB activation [91,92]. A possible explanation for this interest-
ing finding might be that caspase-8 is regulated by c-FLIPL as described in
1.3.1. This hypothesis is strengthened by different studies which suggest an
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involvement of c-FLIPL in NF-κB activation (summarized in [93]).
An interesting observation during the study of caspase-8 dependent NF-κB
activation was the recruitment of the DISC into lipid rafts within the cell [94].
Therefore, the delicate balance between cell death and cell survival seems to
be regulated by the specific location of active caspase-8 within the cell. In
contrast to its cytosolic location during apoptosis, caspase-8 is bound to a
different environment in the lipid rafts during its anti-apoptotic activities,
exposing the protease to a different set of substrates.
To date it is not known whether the multiple involvement of caspase-8 in sur-
vival pathways is dependent on its enzymatic activity or if it serves merely
as a scaffold. Although the presence of active caspase-8 contributes to some
extend to the activation of NF-κB, it has been difficult to identify putative
caspase-8 substrates. The dual killing and survival functions of caspase-8
will have to be investigated in more detail. Its apical position in the ex-
trinsic pathway makes it a highly sought after target for drug development.
However, currently it is not possible to influence the cell death mechanisms
of caspase-8 without disturbing its survival functions and vice versa.
Chapter 2
Binding of Procaspase-8 to
FADD
2.1 Introduction
Protein domains belonging to the superfamily of death domains are involved
in a variety of different pathways. They play an important role in caspase ac-
tivation during apoptosis and inflammation but also mediate protein/protein
interactions in other situations (reviewed in [44,45]). Four different sub-
families of death domains have been distinguished so far: death domains
(DD), death effector domains (DED), caspase recruitment domains (CARD)
and pyrin domains (PYD). DDs and DEDs ar mainly involved in apop-
totic signaling whereas PYDs play important roles in inflammation. CARDs
have been found to be involved in both processes. The death domain su-
perfamily proteins share a common hexa-helical fold in Greek topology ar-
rangement. Structural and mutational studies revealed different regions on
the surfaces of death domains to be responsible for protein/protein interac-
tions [43,45,49,53,72,73,95–97]. However, death domain interactions are so
far only known to occur between members of the same family, i.e. DD with
DD, DED with DED, CARD with CARD and PYD with PYD.
The extrinsic pathway of apoptosis is initiated by formation of the death
inducing signaling complex (DISC), which serves as a platform for caspase-8
activation (Figure 1.4; [98]). This complex is formed by homotypic DD/DD
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and DED/DED interactions between the involved proteins. Upon an apop-
totic stimulus an extracellular Fas ligand binds to the transmembrane Fas
receptor, which contains a DD at its C-terminal cytoplasmic part. This DD
directly interacts with the C-terminal DD of the adapter protein FADD. Via
its N-terminal DED, FADD then recruits procaspase-8 and -10 as well as
the caspase-8 homologue FLIP into the complex, the latter all containing
tandem DEDs at their N-terminal prodomain. Binding of the procaspases
leads to dimerization and thus activation of the enzymes.
Although the individual DISC components have been extensively character-
ized the structure and stoichiometry of the complex are unknown. Structural
information is available for individual domains. The DDs of Fas and FADD
and full-length FADD have been structurally investigated by solution NMR
(Figures 1.7B, D and 1.8A on pages 12 and 14, respectively; [47,48,73]). In
addition, information on the DD/DD interaction between Fas and FADD is
known by a crystal structure of this complex [49]. Whereas the individual
domains share the common hexa-helical fold of the death domain family, the
structure of the complex reveals a different conformation in the sixth and
last helix of the Fas DD upon binding of FADD. This helix shifts by approx-
imately 40Å and forms an extension of helix 5. This conformational change
exposes a hydrophobic surface on Fas, the binding site for FADD. Addi-
tional oligomerization mediated by the extended helix 5 and 6 was observed
in the crystal structure, where each assymetric unit contains four Fas and
four FADD molecules [49]. In general, the death domains involved in DISC
formation are highly aggregation prone. However, whether this aggregation
also occurs in vivo, enhancing oligomerization of the DISC and thus caspase
activation, is still unknown.
So far, no structural information is available regarding the binding between
FADD and the prodomain of caspase-8. The structure of full-length FADD
was solved by NMR (Figure 1.7 D) but the prodomain of caspase-8 is struc-
turally unknown. However, it can be assumed that it adopts a similar con-
formation as was seen for the caspase-8 homologue MC159, a viral FLIP
(Figure 2.6 B on page 33, [72]). In this structure the tandem DEDs adopt a
dumbbell-shaped conformation with the two DEDs representing the weights
at each site (Figure 1.7 E). The first DED in the structure is different from
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the typical death domain fold by a missing α helix 3 but two additional
helices at the N- and C-terminal, respectively. Interactions between the two
DEDs are of hydrophobic nature, with a hydrophobic surface of the first
DED1 being in contact with a region in the second DED, which is located
on the opposite site as the patch in the first DED. It is still unknown whether
this interaction is representative for DED interactions. However, it is differ-
ent from the interactions observed in homotypic complexes of other death
domain superfamily members i.e. the DDs of Pelle and Tube or the CARDs
of caspase-9 and Apaf-1 (Figure 1.7 C, F; [53,95].
The structure of MC159 and mutational studies on FADD suggest interac-
tion between the two proteins [72,73,96,97]. The exact nature of the binding
is still unknown but would provide important information to understand
DISC formation and thus apoptosis regulation. This work was set out to
biochemically and structurally characterize the interaction between FADD
and the prodomain of caspase-8. For that pull-down studies were performed
to determine, which parts of the prodomain are involved in FADD bind-
ing. Furthermore, pull-down experiments were used to analyze the impor-
tance of disulfide bridge formation in FADD binding as well as intermolecu-
lar prodomain oligomerization. Initial experiments were performed towards
the determination of the three-dimensional structure of the FADD/caspase-8
prodomain complex.
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Figure 2.1: Summary of pull-down results from C. Ghisleni
A) Overview of the different protein combinations used in the pull-downs.
FADD, either alone or in complex with bound DED12 was used as a bait to
pull-down the proteins indicated on the top of the table. "+" and "-" indicate
binding and no binding between the proteins, respectively. Combinations
with no signs have not been investigated.
B) Schematic drawing of interpretation of pull-down results.
2.2 Results
2.2.1 Summary of previous results by Ghisleni, et al.
The following work is based on a diploma thesis by Claudia Ghisleni [99].
She designed and cloned single DED and double DED constructs of caspase-
8 prodomain to perform pull-down experiments using GST-FADD bound to
glutathione sepharose beads as a bait. In these experiments it was possible to
pull-down the full-length caspase-8 prodomain DED12 but not the individ-
ual domains DED1 and DED2, suggesting that both domains are involved in
binding FADD. Interestingly, simultaneous addition of separate DED1 and
DED2 did not result in binding of either one of them. This indicates that
both domains function as a single unit in FADD binding (Results summa-
rized in Figure 2.1 A).
After protein purification mass spectrometry was performed to verify the
correct protein masses. The obtained masses indicated the formation of a
disulfide bridge between β-mercaptoethanol molecules from the buffer and
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prodomain constructs containing DED2 either as a single unit or in combina-
tion with DED1. In addition, dimerization of these constructs was observed
on SDS PAGE. The sequence of DED2 contains two cysteines in DED2 at
position 130 and 163. Mass spectrometry in combination with proteolytic
digest of the full-length prodomain indicates that Cys130 is surface exposed
and involved in disulfide bridge formation whereas Cys163 is buried.
To investigate the role of Cys130 and Cys163 further, pull-down studies using
the FADD/DED12 complex and single DED2 were performed (Figure 2.1 A).
Interestingly, DED2 can be pulled down by the FADD/DED12 complex and
this interaction was found to be inhibited at high concentrations of reducing
agents or mutation of Cys163 to serine in DED2. Therefore, Ghisleni et al.
suggested an additional oligomerization of the caspase-8 prodomain via disul-
fide bridge formation between DED2s of proximal procaspase-8 molecules
(Figure 2.1 B). However, the biological relevance of this finding still is still
unknown.
2.2.2 Pull-down experiments
The main goal of this work is the structural determination of a complex
between FADD and the caspase-8 prodomain DED12. To get a better un-
derstanding of this system, first experiments were performed to confirm and
expand the pull-down results described above [99]. A previously designed
but unused DED12 C130S construct was included in the analysis and an ad-
ditional DED2 C130S construct was designed. Furthermore, TEV protease
cleavage sites were introduced right before the coding sequence for FADD
and the full-length prodomain to allow removal of these tags prior to crys-
tallization. An overview of the final constructs is shown in Figure 2.2.
Expression and purification of FADD and procaspase-8 was performed as
described previously with minor differences. In contrast to the previous
diploma work expression of all constructs was performed in BL21(DE3) cells.
Different strains did not enhance expression or solubility levels. Very impor-
tant was the use of unbaﬄed flask for expression of the prodomain constructs.
Using baﬄed expression flasks resulted in complete insolubility of the pro-
teins.
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Figure 2.2: Overview of constructs used in pull-down experiments
Schematic drawing of the constructs for A) Fas, B) the bait protein FADD
and C) the prodomain single (DED1 and DED2) and double constructs
(DED12). The individual fusion tags are displayed. C130S and C163S mu-
tations in DED2 are indicated by "*". The TEV cleavage sites are presented
by arrows.
The expression level of GST-tagged FADD was very high. Purification of
one liter of culture yielded more than 100 mg of soluble fusion protein with
high purity (Figure 2.3 A). Expression of the prodomain constructs proved
to be less effective. Especially, the full-length prodomain had a much lower
expression level. Furthermore, purification of single and double DED con-
structs did not yield sufficiently pure material for structural work (Figure
2.3 B,C). However, for pull-down experiments the purity of the proteins was
adequate. Western blot analysis of all proteins included in the pull-down
experiments showed single bands for proteins carrying a C-terminal His-tag
as displayed in Figure 2.3 D. Fas, FADD and GST-SGT1 do not contain a
C-terminal His-tag and therefore were not detected.
The individual DEDs and full-length prodomain were analyzed for their abil-
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Figure 2.3: Purification of proteins for pull-down experiments
SDS PAGE of individual purification steps for A) GST-FADD, B) the single
GB1-DED construct DED1 and C) the double GB1-DED construct DED12.
The first lanes following the marker show the whole cell lysate, which was
loaded on the column (Load), the unbound flow-through (FT) and the flow-
through from washing the column (Wash). The numbers indicate the eluted
fractions.
D) Western blot on purified proteins used in pull-down experiments. The in-
dividual proteins are indicated above the lanes. Detected was the C-terminal
His-tag on the prodomain constructs. GST-FADD, GST-SGT1 and Fas do
not have a C-terminal His-tag.
ity to bind FADD. A schematic drawing is displayed in Figure 2.4 A. GST-
SGT1 was included in the pull-down as a negative control to exclude that
the prodomain binds to the GST fusion tag. No binding was observed for
the negative controls. As expected from former results [99], the individ-
ual DEDs did not bind to full-length FADD even when co-incubated. In
contrast, full-length prodomain bound to FADD and this binding was not
inhibited by mutation of either one of the cysteines or high concentration of
DTT. Thus binding of procaspase-8 to FADD does not depend on disulfide
bridge formation.
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Figure 2.4: GST pull-down experiments to determine FADD/prodomain in-
teractions
A) Pull-down of single or double DED constructs with GST-FADD as a bait.
The proteins included into the pull-down are indicated above each lane
B) Binding of DED2 to the FADD/DED12 complex. Single and double
domains were used as wild-type protein (WT) or with the C130S (130) or
C163S (163) mutation as indicated above the blot.
Previous experiments by Ghisleni et al. suggested the formation of a disulfide
bridge between cysteines in DED2. To verify this hypothesis wild-type DED2
or either one of the DED2 mutants were incubated with the FADD/DED12
complex (Figure 2.4 B). Indeed, it is possible to pull-down DED2 and DED2
C130S with the FADD/DED12 complex as observed by the appearance of
an additional band for the single DED2 constructs. In contrast, no bind-
ing of DED2 C163S to DED12 was detected, which confirms the results by
Ghisleni, et al. [99]. However, the reverse setup using wild-type DED2 and
DED12 C163S leads to formation of a FADD/DED12/DED2 C163S complex
as evident by bands for both prodomain proteins. In addition DED12 C130S
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was also able to bind DED2 as effectively as wild-type DED12. Thus, muta-
tion of either one of the two cysteines in DED12 does not prevent binding of
DED2. Furthermore, addition of high concentrations of DTT did not abolish
this interaction indicating that the interaction between DED12 and DED2
is not dependent on disulfide bridge formation.
2.2.3 Analysis of the biological relevance of disulfide bridge
formation in vivo
To complement the results from mass spectrometry and the pull-down ex-
periments we characterized the influence of the cysteine mutations in vivo.
Preliminary experiments were performed by transfecting Cos cells with full-
length wild-type caspase-8 or either one of the cysteine mutants C130S and
C163S (Figure 2.5). Expression of all constructs was confirmed by detection
of caspase-8 in Western blots. Activity of caspase-8 was analyzed by co-
expression of caspase-8 with its substrate caspase-3. Processing of caspase-3
into the small and large subunit indicates that all caspase-8 constructs are
active (Figure 2.5 A).
An interesting observation from the initial expression tests was that the
C130S mutant shows higher signals in the Western blots as compared to
wild-type caspase-8 and C163S, although the same amount of DNA was
used for transfection (Figure 2.5). This effect could either be attributed to
a higher expression level, an increased stability or to a decrease in prote-
olytic processing of this mutant. A reduced self processing rate would result
in lower levels of active caspase-8 in the cells and therefore less caspase-3
processing. However, levels of cleaved caspase-3 are slightly elevated using
C130S and this increase correlates well with the increased expression level.
Thus the C130S mutant is as active as wild-type and C163S but is expressed
at higher levels or has an increased stability.
Higher expression levels for C130S as compared to wild-type and C163
were also observed using the corresponding catalytic mutants of caspase-
8 (C285A) for transfection. These C285A mutants are incapable of self-
processing and therefore stay in their full-length form. All of these mutants
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Figure 2.5: Overexpression of wild-type caspase-8 and cysteine mutants in
Cos cells.
A) Expression analysis of inactive caspase-1 (control) and active caspase-8
constructs at 16 and 24 hrs after transfection by detection of a C-terminal
Myc-tag. Caspase-8 activity was analyzed by processing of caspase-3 into
the individual subunits. The large subunit (p17/p19) was detected using a
specific caspase-3 antibody. Equal expression levels of β-actin allow compar-
ison of the samples.
B) Expression analysis of active vs. inactive caspase-8 constructs analagous
to A). Detected was the p18 subunit of overexpressed and endogenous
caspase-8.
show a more intense signal for full-length caspase-8 on western blots as com-
pared to their active counterparts. The lower levels of the full-length active
caspase-8 mutants are most likely due to partial processing and thus forma-
tion of active caspase-8.
2.2.4 Comparison of the caspase-8 prodomain with viral FLIP
MC159
In addition to the pull-down experiments and the in vivo studies described
above we compared the caspase-8 prodomain with its homologue FLIP of
which a crystal structure is available (Figure 2.6 A; [72]). In that structure
the two DEDs are arranged side by side with α helices 2 and 5 of DED1
forming hydrophobic contacts with α helices 1 and 4 of DED2 which are
located on the opposite side of DED2 than helices 2 and 5. Sequence com-
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Figure 2.6: Comparison of the procaspase-8 prodomain with viral FLIP
MC159
A) Crystal structure of MC159 (PDB code 2BBR). The second view is ro-
tated by 90◦ around a horizontal axis. The helices are numbered according to
generell DED numbering. Helix 3 of DED1 is missing. The MC159 residues
aligning with the cysteines in the caspase-8 prodomain that were mutated
in this study are indicated as red sticks.
B) Sequence alignment of procaspase-8 (PC8) and MC159. The positions of
the α helices in MC159 are displayed above the sequence. The labeling of the
helices corresponds to A). The mutated cysteines of caspase-8 are indicated
with red letters. "*" defines sequence identity. ":" and "." stand for high
and less sequence similarity, respectively.
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parison of the prodomain caspase-8 with FLIP revealed about 25% sequence
identity and 37% similarity indicating that both proteins are also likely to
be structurally similar. This allows allocation of the approximate positions
of Cys130 and Cys163 in the corresponding region of the FLIP structure.
According to this analysis, Cys163 is buried between helices 1, 5 and 6 of
DED2. Therefore, a biological relevant role of Cys163 in caspase-8 oligomer-
ization is unlikely. In contrast, Cys130, which is located in helix 3 is probably
surface exposed and therefore available for intermolecular contacts.
2.2.5 Complex formation between full-length FADD and the
prodomain of caspase-8
According to the pull-down experiments described in this work, complex for-
mation between FADD and caspase-8 prodomain is feasible. The main goal
of this work is to characterize this complex structurally. Therefore, sufficient
amounts of pure material are needed. Different strategies were applied to
obtain the complex: i) Expression and purification of individual proteins
and subsequent complex formation, ii) separate expression of proteins and
co-purification of the combined proteins and iii) co-expression and purifica-
tion of the complex. In the following paragraph initial experiments for all
three strategies will be described.
For expression and purification of individual FADD and DED12 the con-
structs from the pull-down studies were used. While separate expression and
purification of FADD was possible, it proved to be difficult for the caspase-
8 prodomain, which precipitated during the purification procedure. It was
even impossible to obtain sufficient concentrations of DED12 to screen for
more optimal buffer conditions. A different strategy to stabilize DED12 dur-
ing the purification process was the addition of purified GST-FADD during
cell lysis. However, subsequent affinity purification did not yield detectable
amounts of complex.
Besides the instability of DED12 another particular problem during the pu-
rification of DED12 was that the protein did not bind efficiently to the Ni-
NTA column as observed by significant amounts of it in the flow-through
(Figure 2.3 C). This suggests that accessibility of the C-terminal His-tag
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Figure 2.7: Overview of available caspase-8 prodomain constructs
Schematic drawing of different prodomain fusion constructs and full-length
caspase-8. The individual fusion tags are displayed. The TEV cleavage sites
are presented by small, caspase-8 self-processing sites by thick arrows. All
constructs were also designed carrying either a C130S or C163S mutation.
might be restricted. To possibly enhance binding to the column as well
as protein stability new DED12 constructs were designed in which the His-
tag was N-terminal to the GB1 solubility tag (Figure 2.7, second construct).
However, the new protein proved to be as unstable as the previous construct.
The use of other solubility enhancing tags such as MBP, NusA etc. (Figure
2.7) did not improve purification or protein stability of individual DED12,
either.
Fortunately, the new fusion constructs with the N-terminal His-tag harbor a
different antibiotic resistance (kanamycin) than the FADD construct (ampi-
cillin). This allows co-expression of FADD and DED12. Previously, GST-
FADD and His-GB1-DED12 were individually expressed in the same cells
using the same expression conditions. Therefore, the same strategy was ap-
plied for co-expression. Surprisingly, the expression level for FADD, which
was very high when expressed individually, dropped dramatically when co-
expressed with DED12. Although both proteins are in the soluble protein
fraction after cell lysis binding to the GST affinity column seems to be in-
hibited (Figure 2.8 A). A significant fraction of protein was found in the
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Figure 2.8: Purification of coexpressed FADD and DED12
A) Complex purification using GST Trap column. The area where the pro-
tein elutes (small box) is displayed at a larger scale on the right side. The
SDS gel with the corresponding fractions (TCA precipitation) is indicated
below the diagram.
B) Analytical size exclusion chromatography using an S200 superdex column.
The peak fractions were submitted to TCA precipitiation and analyzed by
SDS PAGE (right)
flow-through and only small amounts of protein eluted from the column.
Nevertheless, the eluted peak contains FADD and DED12 in approximately
1:1 stoichiometry as judged by the intensity of the bands on an SDS gel.
This material also eluted as a single peak from an analytical size exclusion
column (Figure 2.8 B).
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2.3 Discussion and Future Directions
Caspase-8 and -10 are activated through binding to the death inducing sig-
naling complex DISC. This complex is formed by trimerization of Fas and
subsequent FADD and caspase-8 and -10 binding. According to the available
crystal structure Fas and FADD bind to each other in a 1:1 ratio [49]. Our
preliminary co-expression experiments indicated also equal ratios of FADD
and caspase-8. Additionally, studies by Ghisleni et al. suggested a further
dimerization of caspase-8 prodomains via disulfide bridge formation result-
ing in additional DISC oligomerization. So far there is no information about
the overall stoichiometry of the individual components in the DISC. How-
ever, it seems that this caspase activation platform is a higher oligomeric
complex [49].
This work was set out to characterize a complex between FADD and its
binding partner caspase-8 but also to evaluate the importance of two cys-
teines, Cys130 and Cys163, in the second DED of the caspase-8 prodomain.
Therefore, we used an expanded set of prodomain mutants in biochemical
experiments as well as in vivo studies. Previous experiments suggested that
Cys130 is located on the protein surface whereas Cys163 is buried inside the
protein [99]. This finding is supported by comparison of the procaspase-8
with the structurally characterized viral FLIP MC159. The more surprising
was the finding that mutation of the buried Cys163 in single DED2 inter-
fered with binding to full-length caspase-8 prodomain. A possible explana-
tion is that mutation of this internal residue effects folding of the domain and
thus interrupts oligomerization. In contrast, mutating Cys163 in full-length
prodomain seems to be ineffective on protein folding, since this domain is
able to bind FADD as effectively as wild-type prodomain. Furthermore, mu-
tation of Cys163 in full-length caspase-8 did not effect its expression in vivo
and this protein is able to processes caspase-3 as effectively as wild-type
caspase-8. Thus this cysteine is not important for FADD interaction or in-
termolecular self aggregation as proposed by Ghisleni et al. who suggested
a biological relevance of this cystein [99].
In contrast, Cys130 shows a different behavior than wild-type in prokaryotic
as well as eukaryotic expression. In both systems the C130S mutants are
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better expressed and more stable than the corresponding wild-type protein.
Because Cys130 is located on the surface of the protein it might theoretically
be involved in oligomerization of the prodomains. Inhibition of this oligomer-
ization has a positive effect on caspase-8 stability and caspase-3 processing,
which is contrary to the hypothesis of Ghisleni et al. [99]. Therefore, this
study reveals that there is no biological relevance of the two cysteines in DISC
formation and thus caspase-8 activation. Wild-type caspase-8 prodomain as
well as both cysteine mutants are able to bind FADD equally well in pull-
down experiments and the corresponding full-length constructs are able to
process caspase-3 in vivo.
Preliminary studies on expression and purification of the FADD/prodomain
complex indicate that it is possible to obtain this complex but so far, it
was impossible to purify sufficient amounts of it for crystallization. A useful
information from the eukaryotic expression studies is the slightly increased
stability of the C130S mutant as compared to wild-type DED12. Since, the
C130S mutation does not interfere with binding of FADD future experiments
will be performed using this mutation for the DED12 constructs.
The high aggregation tendency of DED12 necessitates the use of solubility
tags for expression and purification. Although proteins can in principle be
crystallized in the presence of fusion tags these tags could also induce crys-
tallization artifacts. Therefore, it is advised to remove these tags prior to
crystallization. However, this most likely results in instability of the individ-
ual prodomain but might be possible after formation of the FADD/DED12
complex, assuming that FADD stabilizes DED12. Optimal conditions for
these fusion proteins alone and in complex with FADD have to be deter-
mined by buffer screening (see Chapter 2.4.2).
Alternatively, a previous work by Roy et al. reported refolding of functional
full-length caspase-8 from inclusion bodies [39]. Preliminary experiments
using either catalytically active or inactive (C285A) full-length caspase-8
showed that it is possible to refold functional protein with this procedure (S.
Engeler, unpublished results). Both variants were able to bind FADD in pull-
down experiments, indicating that the prodomain was properly folded. Fur-
thermore, the catalytically active construct was able to cleave the tetrapep-
tidic Ac-DEVD-AMC substrate, verifying successful refolding of the catalytic
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domain. This full-length caspase-8 will provide a different strategy to ob-
tain the FADD/DED12 complex. Full-length caspase-8 can be incubated
with FADD. Afterwards, processing of the natural cleavage site between the
prodomain and the catalytic domain of caspase-8 will give rise to the desired
complex. An N-terminal His-tag of the prodomain can then be used for fur-
ther purification of this complex.
One possibility for the poor recovery of the complex from affinity columns
might be that as a complex binding of the affinity tags to the column resin
is compromised. For example, individual GST-FADD binds well to the GST
Trap column (Figure 2.3 A) whereas the complex is found mostly in the
flow-through (Figure 2.8 A). This problem could be circumvented by cloning
a longer linker between GST and FADD or removal of the GST-tag prior to
complex formation. The latter strategy requires the optimization of buffer
conditions for untagged FADD. A TEV based buffer screen (see Chapter
2.4.2) using high concentrations of GST-FADD might provide first ideas
about more optimal buffer conditions for stable untagged FADD.
A different strategy would involve the use of only the FADD DED instead
of full-length FADD for complex formation. A previous study describing
the structure of a complex between the DDs of Fas and FADD states an
increased stability of this complex when using only the DD of FADD instead
of the full-length protein [49]. Analogous, the use of the single DED could
stabilize the FADD/DED12 complex.
This section describes different strategies to obtain a a stable complex be-
tween FADD and the prodomain of caspase-8. Although the main goal is
to crystallize this complex additional biochemical and biophysical experi-
ments have to be performed to gain a better understanding of the stability
and solubility properties of it. In addition, analytical ultracentrifugation
or light scattering have to be used to elucidate the exact stoichiometry of
the complex, and to answer questions, such as whether this complex is of
higher molecular order electron micrsocopy could provide further insight. In
addition, the binding affinity between FADD and the prodomain will be an-
alyzed by Biacore experiments. A particular interesting question to answer
is whether there is a difference in binding affinity of full-length caspase-8
versus only the prodomain to FADD.
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2.4 Experimental procedures
2.4.1 Protein design, expression and purification
DNA sequences coding for human caspase-8 residues 1-84, 93-180 and 1-180
were cloned into the pET-20b(+) vector (Invitrogen) to yield the constructs
DED1, DED2 and the full-length prodomain DED12, respectively. The vec-
tor was modified to contain an N-terminal GB1 solubility tag. Additional
Cys to Ser mutations were introduced by Quikchange mutagenesis (Strata-
gene). Full-length prodomain constructs were further modified to contain
a TEV cleavage site, which was introduced by ligation of annealed oligos
containing the TEV coding sequence into a BamH I site directly N-terminal
to the DED12 sequence. All constructs contain a C-terminal hexa-His-tag.
Full-length FADD was cloned C-terminally to the GST-tag into the pGEX-6
vector (Qiagen). An additional TEV site was introduced prior to the FADD
coding sequence as described above.
FADD an the prodomain constructs were either separately expressed or co-
expressed in BL21(DE3) cells in LB media. Protein expression was induced
with 1 mM IPTG at OD600 = 0.5. Caspase-8 constructs were expressed in
unbaﬄed flasks for four hours at 37◦C. FADD was produced at 18◦C over
night. Cells were harvested, resuspended in PBS or 20 mM Tris 8.0, 100
mM NH4Cl, 0.5 mM TCEP for FADD and caspase-8 prodomain constructs,
respectively. Cells were lyzed by French press (2 passes at 10,000 - 12,000
PSI), the soluble protein fractions clarified by centrifugation at 24,000 x g for
30 min and applied to the corresponding affinity columns, equilibrated with
the corresponding lysis buffer. The caspase-8 prodomain constructs were
purified by Ni-NTA. Elution was achieved by addition of 200 mM imidazole
to the described lysis buffer. FADD was loaded onto a GST trap and eluted
with lysis buffer containing 10 mM reduced glutathione.
2.4.2 Protein stability tests
The individual proteins and complexes were tested for their optimal buffer
conditions using an incomplete factorial screen [100]. Screening was per-
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formed against buffers with pH values between 4.5 and 9.0 and different
salts at various concentrations. Plates were set up using a Phoenix liquid
handler (Art Robbins Instruments). To screen for optimal protein stabil-
ity drops were mixed containing 100 nl protein and 100 nl mother liquor.
Protein stability after TEV cleavage was assayed by mixing drops of 800
nl protein and 800 nl mother liquor and addition of 100 nl TEV protease
(stock concentration 2 mg/ml) to the mix. All plates were incubated at
20◦C and monitored for several days. Buffer conditions were precipitation
was observed were considered as not optimal.
2.4.3 Pull-down experiments and Western Blot
All pull-down experiments were performed in 100 mM sodium phosphate
buffer pH 7.0, 100 mM NaCl, 1 mM PMSF, 0.5% NP40, and either 1 or 20
mM DTT. 50 µl glutathione sepharose beads (Amersham) were equilibrated
with the pull-down buffer and incubated with GST-FADD for two hours at
4◦C. Unbound FADD was removed by washing the beads four times with the
pull-down buffer. The required FADD binding proteins were added in five-
fold excess, incubated and left over protein washed out as described before.
If indicated, a third component was added following the same procedure.
The washed beads were resuspended in 80 µl SDS loading buffer, proteins
were separated by SDS PAGE and blotted onto a PVDF membrane. The
membrane was blocked with 5% milk in high-TBST (50 mM Tris pH 7.0,
500 mM NaCl, 0.2% Tween-20) for one hour at room temperature. Alkaline
phosphatase conjugated ∝-His scFv-PhoA antibody (Qiagen) was dissolve
1:1000 in high-TBST containing 0.5% milk and incubated for one hour. Af-
terwards, the membrane was washed twice each with high-TBST, high-TBS
(50 mM Tris pH 7.0, 500 mM NaCl) and H20. Alkaline phosphatase activity
was detected by addition of 100 µl NBT-BCIP (Fluka) in 5.7 ml 100 mM
Tris pH 8.8, 10 mM NaCl, 5 mM MgCl2.
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3.1 Abstract
Caspases are proteases with an active-site cysteine and aspartate specificity
in their substrates. They are involved in apoptotic cell death and inflam-
mation, and dysfunction of these enzymes is directly linked to a variety of
diseases. Caspase-8 initiates an apoptotic pathway triggered by external
stimuli. It was previously characterized in its active inhibitor bound state
by crystallography. Here we present the solution structure of the monomeric
unprocessed catalytic domain of the caspase-8 zymogen, procaspase-8, show-
ing for the first time the position of the linker and flexibility of the active
site forming loops. Biophysical studies of carefully designed mutants al-
lowed disentangling dimerization and processing, and we could demonstrate
lack of activity of monomeric uncleaved procaspase-8 and of a processed but
dimerization-incompetent mutant. The data provide experimental support
in so-far unprecedented detail, and reveal why caspase-8 (and most likely
other initiator caspases) needs the dimerization platform during activation.
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3.2 Introduction
Apoptosis is a highly regulated process in multicellular organisms where un-
wanted or diseased cells self-destruct. It plays a crucial role in all higher
organisms. During embryonic development it is important in shaping the
nervous system, organs and extremities [101]. Later on, various intra- or ex-
tracellular signals, such as genome damage, cytotoxic stress or environmental
insults, can trigger apoptotic cell death [102,103]. Moreover, it functions in
the regulation of immune response, for example, in elimination of virus-
infected cells or selection of educated immune T cells [29,104]. Defects in
the apoptotic machinery are closely linked to a variety of developmental and
neurodegenerative diseases as well as cancer [28,30]. Because of its central
role in maintaining homeostasis of cells in multicellular organisms including
mammals and humans, apoptosis has been extensively studied to provide
a better basis to fight diseases in which it is deregulated [105]. However,
despite extensive research apoptotic signaling is not fully understood, and
major questions remain unanswered, in particular concerning the nature of
and the interaction between the different proteins involved in this process.
A crucial role during apoptosis is played by caspases, a class of cysteine
proteases with specificity for aspartic acid in the P1 position of their sub-
strates. A subgroup of them, called executioner caspases, is responsible for
the cleavage of a variety of substrates, which ultimately result in morphologi-
cal changes associated with apoptosis [106]. They are produced in the cell as
inactive dimeric zymogens, and become activated by proteolytic processing
of a linker, an event that is orchestrated by upstream so-called initiator or
apical caspases. Processing separates each catalytic unit of the dimer into
a large (∼p20 or α) and a small (∼p10 or β) subunit, and is subsequently
followed by a rearrangement of the linker and loops in order to form the
active site of the executioner caspases [107].
Although the activation mechanism of executioner caspases is well under-
stood, the exact mechanism of activation of initiator caspases still needs to
be established. In contrast to the dimeric executioners of apoptosis, the ini-
tiators are expressed as inactive monomeric zymogens. These apical caspases
are activated upon binding via their N-terminal prodomains to macromolec-
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ular complexes, such as the death inducing signaling complex (DISC), the
apoptosome or PIDDosome [40,57,96]. By that means they are brought into
close proximity and dimerize. Subsequent autoproteolytic cleavage of the
zymogens results in separation of the catalytic unit in two subunits. An
additional cleavage event between the prodomain and the catalytic domain
allows release of the active enzyme from the activation complex. It was long
debated, whether dimerization or cleavage is responsible for initiator cas-
pase activity. Muzio et al. introduced the induced proximity model, which
postulates dimerization as the sole requirement for initiator caspase activa-
tion [37]. Experiments on caspase-8, using inducible dimerization systems,
revealed that caspase-8 can be activated by dimerization, independent of
cleavage of the linker. This finding was later confirmed by other groups us-
ing different experimental approaches, some of which were also applied to
other caspases [36,64,67,108].
Caspase-8 is involved in the extrinsic pathway of apoptosis; extrinsic, because
of the origin of the apoptotic stimulus. This pathway starts with binding
of an extracellular Fas ligand to the transmembrane Fas receptor. Ligand
binding induces oligomerization of the receptor, which probably triggers in-
tracellular conformational changes. This results in binding of the adaptor
molecule FADD to the Fas receptor via homophilic death domain interac-
tions. FADD further recruits procaspase-8, which binds via its N-terminal
prodomain comprising two death-effector domains. This prodomain is joined
via a 50-residue linker to a ∼270 amino acid catalytic domain, which contains
two caspase-8 cleavage sites for autoproteolytic processing. Two additional
cleavage sites exist within the catalytic domain, allowing it to be processed
into two different subunits, termed α or p18 and β or p11.
Several structures of active cleaved caspase-8 with different inhibitors bound
have been determined over the last years, and substantially improved our
understanding of substrate binding and specificity [65,66,68]. In contrast,
to date knowledge on the structure of the zymogen and on conformational
differences between the zymogen and the active enzyme is still missing. Here
we present the structure of the catalytic domain of caspase-8 in its zymogen
state that, together with biochemical studies using mutants with different
properties for processing and dimerization, allows a description of the activa-
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tion and dimerization mechanism of caspase-8. We experimentally identified
two different factors important for dimerization and showed the importance
of cleavage on the stabilization of active caspase-8.
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3.3 Results
3.3.1 Procaspase-8 structure determination
To investigate the activation mechanism of caspase-8, we determined the so-
lution structure of a single-chain mutant of caspase-8 by using nuclear mag-
netic resonance (NMR) techniques. Therein, Cys285 within the catalytic
domain was replaced by Ala in order to prevent intersubunit cleavage (the
numbering follows the caspase-1 nomenclature; Cys360 in full-length caspase-
8). Moreover, to facilitate the recombinant production, the prodomain was
excluded in the construct that will be designated in this work as procaspase-
8.
This mutant was expressed as a single-chain construct in E. coli, purified
to homogeneity and characterized by biochemical methods. Analytical ul-
tracentrifugation measurements displayed a single peak at ∼30 kDa, char-
acterizing it as purely monomeric (Table 3.1). This view was additionally
confirmed by the line widths in the [15N, 1H] heteronuclear single quantum
coherence (HSQC) NMR spectra (Figure 3.1 A) even at concentrations as
high as 1mM, and this observation is in clear contrast to the behavior of
active caspase-8, which exists in a monomer-dimer equilibrium.
Backbone and side-chain assignments were completed to 80% and 82%, re-
spectively. Triple-resonance experiments on deuterated samples were used
for backbone assignments, while HCCH total correlated spectroscopy (TOCSY)-
type experiments were used for assigning the side-chain resonances. A de-
tailed description of the assignment process is provided in the Supplemen-
tary Material. Assignments in the proton-nitrogen correlation maps could
not be made for the first ten N-terminal amino acids and for residues from
loops 4 and 5. This is particularly surprising because no peaks without as-
signments remained in the [15N, 1H]-HSQC spectrum. From inspection of
the corresponding strips in the 3D triple-resonance and 15N-resolved nuclear
Overhauser enhancement spectroscopy (NOESY) spectra accidental overlap
of these peaks with other amide resonances can be excluded. Moreover,
spectra recorded at both 500 and 900 MHz did not yield additional signals.
We suspect that those signals are broadened beyond detection due to con-
formational exchange processes. Excluding these regions the completeness
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Figure 3.1: Dynamic analysis and solution structure of procaspase-8.
A) 700 MHz [15N, 1H]-HSQC spectrum of procaspase-8 recorded at 305K.
B) 15N {1H}-NOE of the backbone amide moieties of procaspase-8. Values
between 0.7 and 1 indicate rigidity of the protein, whereas values below
0.5 imply increasing flexibility. Values below 0 indicate complete loss of
structure. Blank regions are due to amides that have not been assigned.
C) Superposition of the backbone atoms of secondary structural elements
of the 20 lowest-energy structures of procaspase-8 as determined by NMR.
The central β sheet is colored blue; the surrounding α helices are shown
in red. The linker is depicted in green. The graphic was produced using
MolMol [109].
D) Stereo model of best energy structure of the 20-structure bundle. The
color coding is the same as described in C. The nomenclature of the different
loops as used in this publication is annotated on the structure. Loops 4 and
5 are not defined in the NMR structure and are modeled as smooth loops
in the presented stereo view. The actual position of these loops is unknown.
For functional stereo view use Figure of publication [110]. This graphic was
prepared using PyMOL (DeLano Scientific LLC, http://www.pymol.org).
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of the remaining parts of the structure was 93% and 95% for backbone and
side-chain assignment, respectively.
Once the backbone assignment was completed 15N{1H}-NOE measurements
were exploited to analyze the backbone dynamics of procaspase-8 (Figure
3.1 B). Heteronuclear NOE values larger than 0.7 indicate that the back-
bone of procaspase-8 is stably folded. In contrast, values in the linker region
decreased to between 0.4 and 0.5, characterizing this long loop as being more
dynamic or flexible but still partly structured, a result that was later con-
firmed in the final structure.
The final structure calculation was based on 2229 NOE-derived upper dis-
tance limits, and 236 torsion angle restraints, obtained from the analysis of
13C α/β chemical shifts using the program TALOS (Supplemental Data).
The 20 structures with the lowest energies were selected from a total of 200
computed structures and further refined using the AMBER force field. The
rmsd of the resulting ensemble of conformers is 1.6 Å, determined by fitting
over the secondary structure elements (see Supplementary Table S1 for re-
finement statistics). The conformer with the best energy statistics will be
used below to represent the NMR ensemble and to discuss the structural
features of procaspase-8 in solution.
3.3.2 The structure of procaspase-8
The structure of procaspase-8 displays the characteristic caspase fold (Figure
3.1 D). Therein, a six-stranded β sheet is formed by five parallel and one
anti-parallel β strand. This core unit is surrounded by five α helices, two
and three of which flank the two sides of the β sheet. Protruding from these
elements are four loops and the linker region. All loops extend from the same
side of the protein. Loop 1 contains a short α helix, encompassing Ala245 to
Lys250, which was also observed in active caspase-8. Loop 2 constitutes the
40-residue long linker that connects the two subunits of the catalytic domain
and traverses across the central β sheet along one side of the protein. The
loops and the linker region of procaspase-8 display increased flexibility when
compared with elements of secondary structure. The less rigid character of
these regions is reflected in increased values of the rmsd (4.24 Å for backbone
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atoms) compared with those of regions of regular secondary structure (e.g.,
1.27 Å for backbone atoms of the β sheet).
The β strands and α helices of procaspase-8 superimpose well with the corre-
sponding regions from active caspase-8 (rmsd of 2.4 Å on average, Figure 3.2
A). Significant differences between the two structures are contained in the
loops and in the linker region, which in the active enzyme form the binding
pocket with the active-site Cys. In procaspase-8 loop 1 is rotated along a
perpendicular axis by ∼90◦ compared with caspase-8 (Figure 3.2 B). In the
zymogen this loop is partially located where the active site will be formed
in caspase-8. In procaspase-8 the position of this loop is defined by eleven
NOEs between loop 1 and 3, as well as by several contacts to the linker, that
partially cover loop 1 (Figure 3.2 B, 3.3). Loop 3 is shifted slightly toward the
putative binding pocket (Figure 3.2 C). Although the difference is small, the
corresponding signals are significantly shifted in the active caspase-8 spec-
trum (see Supplemental Data for spectra). Even though the backbone cannot
be traced through loops 4 and 5 in the presented structure, we conclude that
the substrate-binding pocket is not present in procaspase-8. Furthermore,
the linker that is cleaved during activation covers most of the putative active
site region (Figure 3.2 E). Modeling of the DEVD tetrapeptide as observed in
the caspase-8 X-ray structure into the corresponding region of procaspase-8
clearly indicates that binding is impossible in the zymogen conformation.
3.3.3 Location, orientation and processing of the linker
To our knowledge, the structure presented here is the first example of a pro-
caspase in which the position of the linker is structurally defined. Although
the backbone dynamics reflected in the 15N{1H}-NOE reveal the linker re-
gion to be more flexible (Figure 3.1 B), its approximate conformation is
determined by various NOE restrains that anchor the loop at various posi-
tions (Figure 3.3). For example, the position of the linker in the vicinity
of the active site is defined by contacts formed between four linker residues
(Thr373, Gln376, Tyr380, Leu381) and two residues from loop 1 (Arg248,
Gln249). In addition, NOEs are observed between linker residue Y392 and
three residues located in loop 3 (K320), in the third α helix (I333) and in the
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Figure 3.2: Comparison of procaspase-8 (blue) with active caspase-8 (red),
respective linker rearrangements and substrate binding.
A) Superposition of the solution procaspase-8 structure with one caspase-8
monomer (1QTN). The missing loops 4 and 5 are omitted in the procaspase-
8 structure.
B-D) Differences in the positions of the loops and the linker. The molecules
are depicted in light colors with the regions of interest shown in bright colors.
Arrows indicate the rearrangements of the loops and the linker fragments
during caspase-8 activation.
B) The top panel shows the rearrangement of loop 1 from procaspase-8 to
caspase-8. The lower panel shows the NOE restrains defining the position
of the procaspase-8 loop 1 respective to loop 3. For simplicity protons are
omitted and restrains applied to the corresponding carbons. The involved
residues are presented as labeled sticks.
C) Rearrangement of loop 3 during caspase-8 activation.
D) Relocation of the linker after processing. The P1 Asp of the two cleavage
sites are shown as labeled sticks. The arrows define the movement of the
C-terminal part of the α subunit (L2 loop) and the N-terminal part of the
β subunit (L2’ loop). The central ten amino acids of the linker are removed
during processing.
E) Binding of a DEVD tetrapeptide (yellow sticks) to the active site pocket
of caspase-8 and modeling of the inhibitor into the corresponding region of
procaspase-8. The linker is shown in green.
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Figure 3.3: Definition of the position of the linker by NOE-derived restrains.
Observed NOEs between linker residues (green) and the rest of the protein
(blue) are indicted by dashed lines. For clarity the hydrogen positions are
omitted and the constraints applied to the corresponding carbons.
fifth β strand (M403), thereby establishing the position of the linker relative
to the core of the protein. Whereas the linker in procaspase-8 forms mul-
tiple intramolecular contacts, the cleaved fragments in the active caspase-8
dimer are dramatically shifted in position (Figure 3.2 D). The C-terminal
end, which is denoted as the L2’ loop, detaches from the protein core. The
N-terminal fragment, termed L2 loop, extends along the top of the molecule
towards the second protomer, where it is trapped into a pocket formed by
the core and the L2’ loop of the second monomer (Figure 3.5 B). The active-
site cysteine is located at the N-terminal end of the linker close to the end
of the last (3rd) β strand of the α subunit. In the published X-ray struc-
tures of caspase-8, this cysteine is easily accessible to the substrates. In the
procaspase-8 NMR structure, Ala285, which replaces the active site cysteine,
is buried by the linker. Movement of the linker shifts the active site cysteine
by about 6 Å into a substrate-accessible position in active caspase-8.
The procaspase-8 linker contains two potential cleavage sites, VETD and
LEMD. The present literature and our own data indicate that both cleavage
sites can be processed intermolecularly by a proximal protease, which could
either be another caspase-8 dimer or a different protease such as granzyme
B [36,37,64]. Interestingly, cleavage sites might also be susceptible for in-
tramolecular self-processing by the active site cysteine. Analysis of the en-
semble of conformers derived from NMR shows a high flexibility in the linker
region with some conformers adopting an arrangement of the linker with the
54CHAPTER 3. STRUCTURAL AND BIOCHEMICAL STUDIES ON PROCASPASE-8
cleavage recognition motifs close to the region, where the active site is formed
in caspase-8. Dimerization might be the trigger responsible for forming the
binding pocket and shifting the linker into it. Thus, we postulate that the
two cleavage sites can be processed in different fashions, intermolecular as
well as intramolecular.
3.3.4 Both cleavage sites have to be processed for full activ-
ity of caspase-8
Different processing experiments have shown that both cleavage sites can be
processed intermolecularly but the question remains whether cleavage at one
particular site is required to allow access to the second site. Accordingly we
designed single-chain active caspase-8 mutants with Ala in the P1 position
of either one of the two cleavage recognition motifs (Figure 3.4). At high
concentrations both mutants, D374A and D384A are processed into the in-
dividual subunits by cleavage at their intact cleavage site.
Because both sites can be processed individually, we have addressed how sin-
gle processing of the linker at these unique sites influences dimerization and
activity. In this study the double mutant DDAA (D374A, D384A) and wild-
type caspase-8 define the initial and final states during activation from the
zymogen to the active protein. Table 3.1 summarizes the data on oligomer-
ization as derived from analytical ultracentrifugation.
Both single-point mutants are less prone to forming dimers, but the affinity
for homodimerization is much more reduced in the case of D384A. At a con-
centration of 100 µM this mutant exists exclusively as a monomer, whereas
low populations of dimers are encountered at higher concentrations. Thus,
processing at both cleavage sites is necessary for forming dimers at levels
comparable to those of the wild-type protein.
Structural changes in the active site of these mutants were monitored by
shifts of the fluorescence maxima of a single tryptophan, Trp420, which is
located in the β subunit near the S2 and S4 subsites of the active-site pocket
and is able to form a hydrogen bond to the P1 Asp of the substrate [68].
Thus, structural changes close to the active site can be monitored conve-
niently by fluorescence spectroscopy (Table 3.1). Absorption maxima at
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Figure 3.4: Overview of caspase-8 constructs. Shown is the catalytic domain
of caspase-8. The two subunits are defined as squares. The positions of the
single amino acid substitutions and truncations are indicated (full-length
caspase-8 numbering; C285A in accordance with caspase-1 numbering).
350.57 nm and 353.47 nm occur for wild-type caspase-8 and the DDAA mu-
tant, respectively, indicating a more exposed Trp environment in DDAA
than in caspase-8. The absorption maxima in the single-point mutants are
351.3 nm in case of D374A, which is closer to the value of caspase-8, and at
352.3 nm for D384A, which resembles more the one of procaspase-8. These
data point to a clear difference in the structural organization of the active
site in procaspase-8, caspase-8 and the partially processed enzymes.
In order to characterize the relationship between dimerization, structural
active-site rearrangements and activity we measured the enzymatic activ-
ity of all mutants using the artificial Ac-DEVD 7-amino-4-methylcoumarin
(AMC) substrate (Table 3.1). As expected from previous studies, the double
mutant DDAA is strongly impaired in activity. D374A shows only a mild
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Mutant Fluorescence Activity [rfu/s] Concentration Sedimentation coefficient Monomer/Dimer
λmax [nm] (% wild type) [µM] Sexp [%]
Procaspase-8 353.38 — 1200 2.4 ± 0.033 / — 100 / —
Caspase-8 350.57 11.37 ± 0.71 100 2.7 ± 0.020 / 4.0 ± 0.030 33 / 67
(=WT) (100%) 250 2.4 ± 0.022 / 3.9 ± 0.035 29 / 71
500 2.2 ± 0.021 / 3.4 ± 0.033 21 / 79
D374A 351.38 8.80 ± 0.82 100 2.4 ± 0.013 / 3.7 ± 0.020 48 / 52
(77%) 250 2.3 ± 0.014 / 3.8 ± 0.023 40 / 60
500 2.4 ± 0.020 / 3.9 ± 0.032 39 / 61
D384A 351.94 7.37 ± 0.76 100 2.8 ± 0.017 / — 100 / —
(65%) 250 2.6 ± 0.020 / 3.7 ± 0.028 58 / 42
DDAA 353.47 0.11 ± 0.01 100 2.4 ± 0.016 / — 100 / —
(1%) 250 2.4 ± 0.019 / — 100 / —
500 2.5 ± 0.022 / — 100 / —
1000 2.4 ± 0.021 / — 100 / —
α-trunc 351.53 0.33 ± 0.03 100 2.3 ± 0.035 / 3.8 ± 0.057 70 / 30
(3%) 250 2.5 ± 0.022 / 3.8 ± 0.034 48 / 51
β-trunc 349.52 12.42 ± 1.01 100 3.0 ± 0.020 / 4.1 ± 0.029 31 / 69
(109%) 250 2.4 ± 0.020 / 3.8 ± 0.031 22 / 78
500 2.2 ± 0.029 / 3.5 ± 0.047 18 / 82
F468A 353.38 0 100 2.4 ± 0.022 / — 100 / —
(0%) 250 2.5 ± 0.021 / — 100 / —
500 2.2 ± 0.029 / — 100 / —
αβF468A 353.38 0 100 2.4 ± 0.019 / — 100 / —
(0%) 250 2.5 ± 0.024 / — 100 / —
500 2.2 ± 0.019 / — 100 / —
Table 3.1: Biochemical analyses of caspase-8 mutants
decrease in activity when compared with wild-type caspase-8, likely due to
reduced dimerization propensity. Considering the highly reduced tendency
for dimerization, it was surprising that D384A displays a substantial amount
of activity.
3.3.5 Dimerization is important for caspase-8 activity
Activation of initiator caspases has often been explained using the induced
proximity model, which proposes a direct relationship between dimerization
propensity and activity [37]. Previously, it has been shown that the dimeriza-
tion mutant T390D (Thr467 in our structure) is unable to induce apoptosis
in HEK293 cells [108]. This mutant introduced a negative charge into the
dimerization interface of caspase-8, which most likely results in repulsion
between the monomers. Because the previous results allow no statements
regarding the processing capability of that mutant we further elucidate the
role of dimerization and processing for caspase-8 activity by characterization
of a F468A mutant (Figure 3.4). Phe468 is located next to the previously
mutated Thr in the terminal β strand of caspase-8. It is important to note
that mutation of the Phe to Ala does not introduce repulsive effects similar
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Figure 3.5: Structural features important for dimerization of caspase-8
A) Backbone trace of caspase-8. The caspase-8 dimer is shown in red and
the linker in green.
B) Close-up highlighting L2 loop interactions. Caspase-8 has the same ori-
entation as in A, with one caspase-8 protomer being shown as a cartoon and
the other as a surface presentation. The L2 loop of one protomer occupies a
pocket formed by the L2’ loop and the core of the other protomer. L2 loop
residues which are deleted in the α-trunc mutant are shown as sticks.
C) Interaction of Pro and Phe residues at the dimerization interface. The
molecule is rotated by 180◦compared with A, now viewing from the back side
of the dimer. Side chains of Pro466 and Phe468 are shown as green sticks.
to those observed for T390D. Instead, Phe468 forms intermolecular contacts
with Pro466 of the other protomer (Figure 3.5 C). Interactions of Pro and
aromatic residues are known to play a pivotal role in the formation of ter-
tiary and quaternary structures [111–113].
As anticipated, the F468A mutant of caspase-8 cannot process itself, al-
though the active site cysteine is present. No cleavage was observed, even at
a concentration of 1 mM at 305 K for several days (data not shown). This
mutant exclusively exists as a monomer according to analytical ultracentrifu-
gation. Moreover, the [15N, 1H]-HSQC spectrum is highly similar to the one
of procaspase-8, both with respect to line widths and position of the vast
majority of peaks (see Supplemental Data for more details) Furthermore, no
binding of the artificial Ac-DEVD-AMC substrate was observed (Table 3.1),
clearly indicating that dimerization is a precondition for caspase-8 activity
and self-processing.
Although mutants at the dimerization interface were previously designed as
single-chain constructs, we also introduced a F468A mutation into an indi-
vidual β subunit (Figure 3.4). Upon mixing with an unmodified α subunit,
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the processed enzyme was reconstituted. This αβ-F468A mutant can not
dimerize and as the corresponding single-chain mutant it possesses no activ-
ity, indicating that cleavage alone is not sufficient for activity (Table 3.1).
Surprisingly, both the single- and the two-chain F468A mutants display the
same fluorescence maximum, indicating very similar active-site arrangements
in both proteins (Table 3.1). Furthermore, [15N, 1H]-HSQC spectra of F468A
and αβ-F468A are mostly identical (Supplemental Data). Peaks correspond-
ing to the linker residues from the L2 and L2’ loop in αβ-F468A have not
changed their positions, whereas signals from the ten amino acids removed
upon cleavage and their directly adjacent residues disappeared. Previous
studies from the Salvesen group indicate that cleavage alone is not sufficient
for activity [36,108]. The above results allow us to conclude that cleavage
does not immediately result in the rearrangements of the L2 and L2’ loops,
which are necessary to form the active site. After cleavage both linker frag-
ments remain in the zymogen conformation. In contrast to the αβ-F468A
mutant, signals in the [15N, 1H]-HSQC spectra belonging to residues in the
L2 and L2’ loops of dimeric wild-type caspase-8 are largely shifted, indicating
different positions of these loops in the dimeric cleaved protein (Supplemen-
tal Data). Thus we conclude that dimerization is necessary to induce loop
rearrangements not only in uncleaved caspase-8 but also in the cleaved en-
zyme.
3.3.6 Caspase-8 processing is important in stabilizing the ac-
tive dimer
The observation that monomeric procaspase-8 possessing an intact linker is
transformed into cleaved dimeric active caspase-8 suggests that the linker
might regulate dimerization in two different ways: the unprocessed linker
could sterically interfere with dimerization, or the cleaved linker could sta-
bilize the formed dimer. The linker does not directly influence dimerization
because it is not positioned in the dimerization region. That result is con-
sistent with prior research on dimeric procaspase-7 that defines that linker
in a place similar to the linker in procaspase-8 [114] (Figure 3.6).
Several groups have stated that the L2 loop contributes important interac-
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Figure 3.6: Structure and sequence comparison of procaspase-8 with other
caspases
A) Superposition of procaspase-8 (blue) and procaspase-7 (brown, Protein
Data Bank code: 1K88). The proteins are depicted in light colors with the
linker residues indicated in bright blue and brown, respectively. The X-ray
structure for procaspase-7 reveals only the termini of the linker.
B) Sequence alignment of the linker segment of different initiator procaspases
and the executioner procaspase-7. The caspase cleavage recognition motifs
are highlighted.
tions for stabilizing the caspase-8 dimer [108,115]. However, to our knowl-
edge no experimental evidence for this hypothesis can be found in the lit-
erature. In order to experimentally test this hypothesis, a set of mutants
was designed where the α and β subunits were truncated C and N termi-
nally, respectively (Figure 3.4). In active dimeric caspase-8, the L2 loop is
sandwiched between the L2’ loop of the other protomer and its core (Figure
3.5 B). The truncations are made such that the interacting parts of the two
subunits are removed. Dimerization states of these α-trunc and β-trunc mu-
tants were analyzed by analytical ultracentrifugation. At a concentration of
100 µM the dimeric form in wild-type caspase-8 is populated to 67% whereas
only 30% dimers can be detected for the C-terminally truncated a mutant
(Table 3.1). This mutant is also almost completely devoid of activity. In
contrast, the β-trunc mutant revealed a slight but reproducible increase in
dimerization accompanied by a small increase in activity. This result was
very surprising because it was believed that the L2’ loop is needed to stabilize
the dimer and the active site [108].
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3.4 Discussion
Programmed cell death is a biological process of prime importance, and
therefore has been in the focus of research for a long time [116]. It was
almost a decade ago that Salvesen and coworkers introduced the induced-
proximity model to explain activation of initiator caspases [37]. The concepts
and mechanisms for triggering initial steps during apoptosis were clearly de-
scribed in their seminal work [36,117,118], but some of the molecular and
structural events underlying this mechanism await experimental verification.
This work is set out to present structural and biochemical data that describe
these events and allow refining of the mechanism.
Activation of procaspase-8 is achieved through dimerization with subsequent
processing of the intersubunit linker [36,37,64,67]. To our knowledge, the
structure of procaspase-8 described in this work for the first time reveals the
position of the intersubunit linker in an initiator procaspase. The active-site
mutant of procaspase-8 is monomeric and assumes the typical caspase fold.
The long intersubunit linker is partially flexible but clearly located on one
side of the central β sheet. High local concentrations of caspase-8 in vivo
or in vitro trigger its cleavage, and the resulting species is predominantly
dimeric [37,66]. Using a set of mutants, two factors particularly important
for dimer stabilization are observed: i) formation of contacts involving the
cleaved linker fragments, and ii) pi-Pro interactions at the central dimeriza-
tion interface. The combination of structural, biochemical, and biophysical
data in this work support many aspects of the induced-proximity model in
unprecedented experimental detail and additionally augment new aspects to
refine the mechanism.
An interesting general observation is that the intersubunit linker in initia-
tor caspases is longer compared with those found in executioner caspases
(Figure 3.6 B). The presented structure of procaspase-8 reveals this linker to
be highly flexible. The linker might thereby adopt different conformations,
some of which are suitable for substrate binding, explaining basal activity of
unprocessed initiator caspases. Dimerization most likely triggers conforma-
tional changes in the linker and the catalytic loops, allowing the active site
pocket to form and become accessible for substrate binding, even without
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proteolytic cleavage. This hypothesis is supported by the observation that
caspase-9, which acts in vivo as an uncleaved dimer [55], possesses a much
longer linker that upon dimerization might allow rearrangement of the un-
processed linker and result in formation of the active site. This implies that
the longer linker of the initiator caspases might be important for their basal
activity.
The induced proximity model proposes that dimerization is the trigger for
initiator caspase activity but not cleavage (reviewed in [115,119,120]). This
view is strongly supported by our data on the F468A mutants. Single-
chain F468A is monomeric and structurally highly similar to procaspase-8
but cannot process itself. The cleaved form is again structurally similar to
procaspase-8, and therefore it is evident that dimerization but not cleavage
is the event responsible for the structural changes.
Proximity-induced dimerization of procaspase-8 at the activation platform
DISC is necessary to induce cleavage of the linker, which subsequently re-
sults in increased affinity for dimerization even when caspase-8 is released
from the DISC [108]. The L2 loop of the cleaved linker extends over the
other protomer as shown in several X-ray structures [65,66,68]. This inter-
action stabilizes the dimer by formation of several hydrogen bonds to the
other protomer, and the resulting structural changes additionally allow for-
mation of the active site. Without this stabilizing effect caspase-8 activity is
reduced to almost the zymogen level. Surprisingly, regardless of the multiple
interactions between the L2’ and the L2 loops, the L2’ loop seems to not
contribute significantly to dimer stability. Truncation of the L2’ loop results
in only a modest effect on dimerization propensity and activity. This ob-
servation suggests that interactions of the L2 loop with proximate residues
of the β subunit of the second protomer are sufficient to keep L2 in place.
In contrast, L2 to L2’ interactions, even though they might be comparably
strong, do not seem to critically contribute to dimer stability. Considering
that L2’ is not located in vicinity of the active site, alterations in its position
or length are not expected to influence activity, compatible with the results
of this study.
Interestingly, not only truncation of the L2 but also elongation of the L2
and L2’ loops has an effect on dimerization. We could clearly demonstrate
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that processing of both cleavage sites is important to achieve full caspase-8
activity. Elongation of either one of the linker fragments by an additional
ten residues significantly affects dimerization and catalytic activity. An op-
timal length of the linker fragments after autoproteolytic processing seems
to be crucial for optimal caspase activity. Analysis of different mammalian
caspase sequences revealed that, in contrast to executioner caspases, they all
contain two cleavage sites in their intersubunit linkers (Figure 3.6 B). Thus,
one could speculate that nature developed a mechanism to process the longer
linker of initiator caspases into fragments with an optimal length for dimer
stabilization and active-site rearrangement.
The crystal structure of the caspase-8 dimer and our linker truncation ex-
periments revealed stabilizing interactions of residues from the processed
linker [65,66]. Although these interactions most likely make a significant con-
tribution to dimer stability, they are obviously insufficient to induce dimer-
ization at the low concentrations in vivo. The kD for homodimerization of
the caspase-8 catalytic domains was proposed to be in the low micromolar
range, well above its nanomolar in vivo concentration [67,108]. Instead, bind-
ing of their prodomains to the activation complex increases their apparent
concentration and thereby enforces dimerization. Subsequently, depending
on the specific type of caspase, the dimers are stabilized differently. Caspase-
9, for example, remains attached to the apoptosome during its course of
action [121]. In contrast, caspase-2 forms a stable disulfide bridge in the
dimerization interface [122]. In the case of caspase-8 the dimer is stabilized
twofold: by translocation of the cleaved linker followed by formation of sta-
bilizing intersubunit contacts, and through interactions at the dimerization
interface. The structure of the caspase-8 dimer reveals close proximity of
Phe468 to Pro466 of the other protomer. Interactions between Pro residues
and pi-systems are strongly stabilizing in nature [111–113]. Replacement of
Phe468 by Ala completely abolishes affinity for dimerization, and makes the
mutant cleavage-incompetent. Because the overall fold is not affected by the
Phe to Ala mutation, it indicates that an interaction directly required for
dimerization has been removed.
Each of the analyzed mutants – the cleavage site mutants, the linker trun-
cation mutant α-trunc, and the dimerization mutants F468A (Figure 3.4) –
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reveal a significant impact on the affinity for dimerization accompanied by
changes in catalytic activity. This strongly suggests that a combination of
both, dimerization affinity and proper cleavage is necessary to achieve full
caspase-8 activity. The two dimer-stabilizing effects analyzed in this arti-
cle provide an explanation for the stability of caspase-8 dimers even after
release from the DISC. Our structural and mutational studies prove that
dimerization is indispensable for formation of the active site and thus for
catalytic activity. This finding fully supports the proximity-induced dimer-
ization model. In addition, our data demand a refinement of this model:
it has to take into account that cleavage is necessary to retain dimerization
after the enzyme is released from the activation complex, and is thus closely
linked to the activation process of initiator caspases.
64CHAPTER 3. STRUCTURAL AND BIOCHEMICAL STUDIES ON PROCASPASE-8
3.5 Experimental Procedures
3.5.1 Protein design, expression and purification
For single-chain constructs the DNA sequence coding for human caspase-8
amino acids 217-479 was cloned into pQE50 (Qiagen). The plasmid was
transformed into M15 (pREP4) cells (Qiagen) and the protein expressed
in LB medium at 37◦C overnight. Two-chain constructs encompassed amino
acids 217-374 for the α subunit and 385-479 for the β subunit. The fragments
were cloned into pET-11d(+) (Invitrogen) and expressed in BL21(DE3) cells
as described above. Amino acid substitutions were generated by Quikchange
(Stratagene) mutagenesis. Linker truncations were prepared by insertion of
a preliminary stop codon in the α subunit or deletion Quikchange mutagen-
esis on the β subunit.
Purification protocols were adapted from published procedures [66,123]. Cells
were harvested, resuspended in phosphate-buffered saline (PBS) and lyzed
by french press. The soluble protein fraction was removed by centrifugation,
inclusion bodies washed in 20 mM Tris pH 8.0, 1 mM ethylenediaminete-
traacetic acid (EDTA), 0.1% LDAO and solubilized in 6.5 mM GdHCl, 20
mM Tris pH 8.0, 2 mM EDTA, 100 mM dithiothreitol (DTT).
Refolding of two-chain constructs was achieved by dilution of equimolar
amounts of the solubilized subunits into 100 mM HEPES pH 7.5, 10% su-
crose, 0.1% CHAPS, 10 mM DTT. After incubation over night at RT the
precipitate was removed by centrifugation. The soluble fraction was concen-
trated, dialyzed against 20 mM HEPES pH 7.5, 10% sucrose, 10 mM DTT
and applied to a ResourceQ anion exchange column (Amersham). Elution
was done with a NaCl gradient and protein fractions were applied to a Su-
perdex 200 (Amersham) using 20 mM Tris, pH 8.0, 100 mM NaCl, 10 mM
DTT.
The solubilized inclusion bodies of the single-chain constructs were added to
an equal volume of acetic acid and the sample dialyzed against 50% acetic
acid. Afterwards the solution was suspended rapidly in nine volumes H2O
and immediately diluted in nine-fold excess of 1 M Tris pH 8.0, 5 mM DTT.
Refolding was performed over night at RT and aggregates removed by cen-
trifugation. During the subsequent concentration step autocatalytic pro-
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cessing took place for those mutants that are able to form a proper active
site. Final purification was achieved by size exclusion chromatography as
described above.
Isotope labeling for NMR experiments was done by expression in M9 minimal
media supplemented with 15NHCl4 and 13C-glucose as the sole nitrogen and
carbon source. Deuteration was obtained by substitution of H2O with D2O.
Purification was performed as described above and the final NMR sample
rebuffered into 20 mM deuterated Tris pH 8.0, 100 mM KCl, 10 mM DTT.
The αβ-F468A mutant was generated by addition of catalytic amounts of
unlabeled active caspase-8 to labeled single-chain F468A and subsequent size
exclusion chromatography.
3.5.2 Assignment and structure calculation
All NMR experiments were recorded at 305 K on a Bruker Avance 600 or 700
MHz spectrometer. For backbone assignment an approximately 79% deuter-
ated, uniformly 13C, 15N-labelled sample was used. HNCACB / HN(CO)CACB
spectra [124] and HN(COCACB)CG / HN(CACB)CG spectra [125] were
used to link sequential amide moieties via matching pairs of Cα/Cβ and Cγ
resonances. In addition, assignment was conducted via matching carbonyl
frequencies derived from the HNCO / HN(CA)CO experiments [126]. Se-
quential amide protons were linked in the HN(CACO)NH experiment [127].
A proton-detected version of the steady-state 15N{1H} heteronuclear Over-
hauser effect sequence was used for measurement of the heteronuclear NOE
[128].
Side chain assignments were performed using HCCH-type experiments, start-
ing from assigned Cα, Cβ and Cγ pairs [129,130] whose carbon chemi-
cal shifts were corrected for the deuterium isotope shifts [131]. The aro-
matic spin system were linked to the aliphatic side chains using data from
CB(CGCD)HD / CB(CGCDCE)HE spectra [132]. Proton frequencies within
the aromatic spin systems were assigned using a ct-HMQC-TOCSY experi-
ment [133].
Backbone and side chain assignment was accomplished in the software CARA
[134]. Thereafter, ATNOS [135] was used to automatically pick and integrate
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15N- and 13C-resolved NOESY spectra. In addition to NOE-derived upper-
distance bounds, chemical shift information was used to derive torsion-angle
restraints in the program TALOS [136]. After the first structure calculations,
peak lists were further modified using the program XEASY [137] and assign-
ment of NOESY crosspeaks was continued using the AUTOASSIGN module
of CYANA [138,139]. To improve convergence during the early stages of
the assignment/structure calculation process the preliminary structure after
the first cycle was replaced by template coordinates derived from caspase-
8 (excluding the loops and the linker). So far unassigned fragments were
defined as proxy residues [140] and CYANA was used to define the proxi-
mate positions of these residues in the structure. The resulting coordinates
for the procaspase-8 structure were energy-minimized in explicit water using
the AMBER force-field [141,142].
3.5.3 Protein characterization
The final masses of all purified constructs and cleavage products were con-
firmed by ESI MS. Protein concentration was determined by UV and Brad-
ford assay (Pierce).
Analytical ultracentrifugation was performed with an Optima XL-1 cen-
trifuge (Beckman Coulter) and a TI50 rotor using epoxy centerpieces (12
mm) with sapphire windows. Samples were run at 20◦C and 42000 rpm.
Absorption was measured between 280 and 305 nm, depending on protein
concentration. Results were analyzed using Sedfit [143].
Tryptophan fluorescence emissions spectra were recorded on a Fluorolog4
(Jobin Ivon) with a Peltier Temperature controller set to 20◦C. 2 µM sam-
ples were excited at a wavelength of 290 nm. Five consecutively measured
spectra were collected between 310 and 400 nm and averaged. The slit widths
for excitation and emission were 10 nm and 5 nm, respectively.
Activity measurements were performed in black 96-well Nunclon microtiter
plates on a GENios platereader (Tecan) using the Magellan6 software. The
final sample volume of 100 µl contained 100 nM enzyme in assay buffer (20
mM PIPES pH 7.2, 1 mM EDTA, 100 mM NaCl, 0.1% CHAPS, 10% su-
crose). The reaction was started with addition of Ac-DEVD-AMC substrate
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at a final concentration of 100 µM and AMC release was monitored by fluo-
rescence emission at 465 nm after excitation at 360 nm. Measurements were
performed in triplicates and the standard deviation was calculated.
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3.6 Accession numbers
Coordinates, chemical shifts and restraints have been deposited in the PDB
and BMRB database under accession codes 2K7Z and 15932, respectively.
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3.8 Supplementary material
3.8.1 Assignment and structure calculation
Backbone resonances of procaspase-8 were assigned using a triply labeled
2H, 13C, 15N-labeled sample. Purification of the protein in aqueous solution
and a refolding step in the procedure assured a quantitative back exchange
of the backbone amide moieties. Backbone assignment was heavily based
on sequential and intraresidual HN, Cα and Cβ correlations derived from
constant-time HNCACB and HN(CO)CACB [124] experiments. As noticed
by others the high-resolution from these experiments and the sign informa-
tion of the peaks that additionally reports on the number of adjacent carbon
atoms was crucial for identification of residue type and sequential assign-
ment. Nevertheless, additional HNCG and HN(CO)CG [125] experiments
to assign the gamma carbons were required to resolve ambiguities, and in
addition proved to be very helpful for side chain assignment purposes. Fur-
thermore HNCA(CO)NH [127] and HNCO as well as HNCACO [126] spectra
were used to link sequential HN and Cα via carbonyl moieties, respectively.
Only the combination of these experiments allowed unambiguous sequential
assignment of the backbone, which was confirmed by connectivities from the
3D 15N NOESY. A comparison of the proton-nitrogen correlation map with
a 15N-TROSY spectrum of deuterated active (wild-type) caspase-8 displayed
much similarity, with many peaks located at identical chemical shifts (Fig.
3.7). Nevertheless, a number of peaks disappeared, and many new peaks
appeared. Transfer of the assignments from procaspase-8 revealed that the
peaks due to loop residues were mostly shifted and those from the linker
region were either completely missing or strongly shifted in the caspase-8
spectra. In contrast, the position of many of the other peaks remained basi-
cally unchanged indicating that the two structures comprise the same over-
all fold, with major differences restricted to the loops, the linker region and
dimerization interface. This finding was confirmed in the final procaspase-8
structure. Deuteration of the sample used for sequential assignment leads to
a deviation of the carbon chemical shifts depending on the number of protons
attached to them as well as the neighboring carbons. In order to proceed
with side chain assignment using the Cα, Cβ and Cγ already obtained from
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the experiments described above the carbon chemical shifts had to be cor-
rected according to Venters, et.al. [131]. The corrected shifts were used in
combination with constant-time-[13C,1H]-HSQC, HCcH-TOCSY and hCCH-
TOCSY experiments to assign aliphatic side chains [129,130,144]. Edited
constant-time-13C-HSQC spectra were used to identify aromatic carbons and
carbonyls. The adjacent protons were assigned by 13C-NOESY experiments.
Aromatic side chains were assigned by the combination of the HCCH-type,
ct-HMQC-TOCSY [133] and 13C-NOESY spectra and linked to the corre-
sponding aliphatic side chains using CB(CGCD)HD and CB(CGCDCE)HE
spectra [132]. After complete assignment the structure determination was
continued as described in Materials and Methods. Since the proton nitrogen
correlated experiments described above suggest a similar secondary structure
fold for procaspase-8 as observed for caspase-8 we substituted the PDB file
computed in the first cycle of the CYANA calculation with a template PDB
from caspase-8 (one monomer of 1QTN). Since the loops and the linker were
expected to be different, they were excluded in the template PDB. An ad-
ditional structure calculation using the final set of upper-distance restraints
confirmed that the template structure did not bias the final outcome of
the calculation, and that the NMR conformer ensemble reflects the confor-
mational space solely sampled by experimental restraints. During the side
chain assignment process we obtained assignment for side chains and side
chain fragments, which were not sequentially assigned so far, mainly due
to missing signals in the proton nitrogen correlation experiments described
above. Furthermore, several glutamine residues showed shift ambiguities,
which did not allow a precise sequential assignment. To identify the se-
quential and structural position of these residues they were defined as Proxy
residues [140]. The work of Ab, et al. presented a proxy library containing
shifts of amino acid fragments as well as some complete amino acids. We
expanded this library to include proxies for all 20 amino acids. The structure
calculation by CYANA suggested the positions of the defined proxy residues
based mainly on NOE restrains. The correct position was manually verified
and gave rise to assignments of nine additional residues.
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Figure 3.7: [15N, 1H]-HSQC spectra of
A) inactive monomeric procaspase-8 (of which the structure was determined
in this paper)
B) active dimeric caspase-8 (TROSY spectrum at 700 MHz)
72CHAPTER 3. STRUCTURAL AND BIOCHEMICAL STUDIES ON PROCASPASE-8
Figure 3.8: Restraints used in the Structure Calculation
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NMR distance restraints:
Total NOE 2229 (100.0 %)
Intraresidual, |i− j|=0 629 (28.2 %)
Sequential, |i− j|=1 710 (31.9 %)
Short-range, |i− j|=1 1339 (60.1 %)
Medium-range, 1<|i− j|<5 429 (19.2 %)
Long-range, |i− j|=5 461 (20.7 %)
Restrained α helical hydrogen bonds per monomer none
Maximal distance restraint violation 0.23 Å
AMBER energies:
Total (mean and s.d. of 20 conformers) -4363 ± 185 Kcal/mol
van der Waals -683 ± 40 Kcal/mol
RMS deviations from idealized geometry:
Bond lengths 0.013 Å
Bond angles 1.7◦
Ramachandran plot statistics:
Residues in most favored regions 73.3 %
Residues in additionally allowed regions 25.4 %
Residues in generously allowed regions 0.9 %
Residues in disallowed regions 0.4 %
RMS deviations from the mean coordinates for bb (heavy) atoms
N, Cα, C’ of residues from β strandsa 1.27 ± 0.23 (2.04 ± 0.25) Å
N, Cα, C’ of residues from β strands and α helicesb 1.64 ± 0.29 (2.34 ± 0.32) Å
N, Cα, C’ of all residues exluding missing regionsc 4.24 ± 0.85 (5.05 ± 0.81) Å
a backbone atoms of the β strands (residues 235-240, 311-314, 353-356, 399-401, 466-469,
280-285) were used for the superposition.
b backbone atoms of the β strands (residues 235-240, 311-314, 353-356, 399-401, 466-469,
280-285) and α helices (residues 267-276, 289-302, 333-337, 422-432, 439-446) were used for the
superposition.
c Loop 4 (405-414) and loop 5 (447-463) are not defined and excluded from the analysis.
Table 3.2: Structural statistics
3.8.2 Comparison of single-chain and two-chain F468A
The [15N, 1H]-HSQC spectra of F468A is highly similar to unprocessed
procaspase-8. The vast majority of peaks are identical. Differences between
the F468A mutant and the procaspase-8 C285A mutant (C360A according
to numbering used in this work) are encountered in the region around the
active site residue 360 (compare Fig. 3.7A and 3.9A). Peak positions of
procaspase-8 do not match for peaks corresponding to residues Ala359 to
Gln362. The peak belonging to Gln358 is slightly shifted and decreased in
intensity indicating that it is mildly affected by the C285A mutation. In ad-
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dition to single-chain F468A we measured the spectrum of cleaved F468A.
The protein was generated by processing of labeled single-chain F468A us-
ing catalytic amounts of unlabelled active caspase-8. During purification
the protein was refolded into its zymogen conformation and afterwards pro-
cessed, mimicking the natural activation process of caspase-8. The spec-
trum for two-chain F468A is again highly similar to the ones obtained for
procaspase-8 and single-chain F468A. Figures 3.10A to C expand a region of
the [15N, 1H]-HSQC spectra of procaspase-8 and single as well as two-chain
F468A with the peaks for the linker residues annotated at positions observed
in procaspase-8. Assignments belonging to non-linker residues are omitted
for clarity. From these data we conclude that peaks belonging to the linker
residues not excised during processing do not significantly change their posi-
tions, whereas peaks corresponding to the central ten amino acids disappear.
This strongly suggests that in the absence of dimerization residues from the
L2 and L2’ loop do not change their conformation significantly upon cleav-
age.
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Figure 3.9: [15N, 1H]-HSQC spectra of
A) Unprocessed F468A
B) Proteolytically cleaved αβ-F468A
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Figure 3.10: Expansion of the [15N, 1H]-HSQC spectrum of
A) PC8 from Figure S1A
B) F468A (spectrum 3.9A)
C) αβ-F468A (spectrum 3.9B)
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4.1 Abstract
Caspases are the key players of apoptosis and inflammation. They are present
in the cells as latent precursors, procaspases, and are activated upon an apop-
totic or inflammatory stimulus. The activation mechanism of caspases has
been extensively studied by biochemical and biophysical methods. Addi-
tional structural information on active caspases with a variety of different
inhibitors bound in the active site is available. In this study we investigated
the cleavage mechanism of caspase-8 from its zymogen to active caspase-8
via solution NMR and by biochemical methods. The intermolecular cleavage
reaction using the catalytically inactive C285A procaspase-8 mutant is trig-
gered by adding caspase-8 and followed by 15N, 1H-NMR spectroscopy. The
spectrum that initially resembles the one of procaspase-8 gradually over time
changes to the one of caspase-8, and disappearing peaks display exponential
decaying intensities. Removal of either one of the cleavage recognition motifs
in the linker or phosphorylation at Tyr380 is shown to reduce the rate of the
cleavage reaction. The data suggest that dimerization repositions the linker
to become suitable for intermolecular processing by the associated protomer.
Furthermore, analysis of inhibitor binding to the active caspase-8 reveals an
induced fit mechanism for substrate binding.
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4.2 Introduction
Caspases are cysteine-dependent enzymes with specificity for aspartic acid in
the cleavage recognition motif of their substrates and are involved in apopto-
sis and inflammation [106,145–147]. In apoptosis, initiator caspases are the
most apical enzymes, which receive the apoptotic signal and activate down-
stream executioner caspases. Initially, caspases are produced in the cells
as inactive zymogens, the procaspases [105,106,145,146]. Inflammatory and
apoptotic initiator procaspases are monomeric and contain an N-terminal
prodomain that facilitates their recruitment to macromolecular activation
platforms such as the death inducing signaling complex (DISC) [39,96],
the apoptosome [40,50], the PIDDosome [43,57] or the inflammasome [41].
Through binding to these complexes their apparent concentration is in-
creased and dimerization is induced. Dimerization then triggers activation of
the initiator caspases as proposed by the induced proximity model [37,108].
While forced into mutual proximity at the activation complexes, autopro-
teolytic cleavage of the intersubunit linker occurs. A second cleavage event
between the prodomain and the catalytic domain releases the active caspase
from the activation complex [64]. For executioner caspases cleavage of the
intersubunit linker constitutes the major event for activation while for ini-
tiator caspases it is dimerization [148].
Fundamental insight into the mechanism of caspase activation has been de-
rived from crystal structures, with most of the structures of active caspases
determined in the presence of inhibitors [149]. Additional crystal structures
of inflammatory caspase-1 and executioner caspase-7 in the absence of in-
hibitors report on structural changes upon inhibitor binding, suggesting an
induced fit mechanism of substrate binding [114,150]. Furthermore, a few zy-
mogen structures are available, e.g. for Drosophila melanogaster Dronc [151],
for executioner procaspase-7 [114], for inflammatory procaspase-1 [152], and
for procaspase-8 [110]. The latter was solved by solution NMR and for the
first time revealed the position of the intersubunit linker in a monomeric
zymogen.
Caspase-8 is one of the best-studied initiator caspases. The recently deter-
mined solution structure of procaspase-8 and the available crystal structures
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of caspase-8 in the presence of various inhibitors provide important informa-
tion to decipher the activation mechanism of caspase-8. Additional muta-
tional studies dissected the interplay between dimerization and proteolytic
cleavage [36,37,63,64,67,108,110]. Although dimerization is required and by
itself sufficient for caspase-8 activity, cleavage of the intersubunit linker at
two different recognition motifs is important for dimer stabilization and thus
is essential for caspase-8 activity [110]. While the importance of dimerization
and cleavage is established experiments that describe the transition from the
inactive zymogen to the activated and to the inhibitor-bound caspase-8, are
not available presently. Attempts to describe the structure of caspase-8 in
the absence of an inhibitor failed so far. In this work we interrogate the
activation mechanism from monomeric, unprocessed zymogen to processed,
dimeric caspase in the absence of inhibitors using solution NMR as the pri-
mary tool. We follow the cleavage reaction in the NMR tube by monitoring
procaspase-8 processing using 15N, 1H correlation NMR spectroscopy. In
addition, we determine to which extent the efficiency of caspase-8 processing
is influenced by the dimerization propensity, by phosphorylation at Tyr380
and by limited proteolysis of the intersubunit linker. Finally, NMR data
are used to evaluate how the structure of the free caspase-8 differs from the
inhibitor-bound form.
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4.3 Results
4.3.1 Processing of procaspase-8 into active caspase-8
To characterize the events leading to activation of caspase-8 on a molecular
level we followed the cleavage process from procaspase-8 to active caspase-8
by NMR. 15N-labelled procaspase was mixed with catalytic amounts (1:10000)
of unlabelled caspase-8. Processing of procaspase-8 by caspase-8 was mon-
itored by recording [15N, 1H]-TROSY spectra. Since only procaspase-8 is
labeled, initially the spectrum resembled the one of procaspase-8, for which
an assignment was obtained previously [110] and gradually over time changed
into the spectrum corresponding to caspase-8. At the beginning of the ex-
periment the narrower lines of procaspase-8 allowed recording spectra in 1
hour intervals. During biochemical processing a decrease of the signal in-
tensity in the spectra occurred for most resonances reflecting the formation
of dimeric caspase-8 accompanied by slight precipitation. Significant line-
broadening is observed for the methyl resonances (Figure 4.1B) correlating
well with increased processing as independently monitored by SDS PAGE
(Figure 4.1A).
While most of the peaks remained unchanged a significant number of peaks
decreased in intensity, and new peaks appeared (Figure 4.2). A few very
strong peaks appeared in the random coil region. Since these signals were
absent in spectra of the separately produced caspase-8, in which the intersub-
unit fragment was removed during purification, they most likely correspond
to the fragment excised during cleavage.
Comparing peak integrals over time we observed an exponential decay of all
peaks (Figure 4.1C). After approximately 30 hours the peaks in the [15N,
1H]-TROSY spectra contain about 30% of their original intensity. An ex-
ample is depicted in Figure 4.1C, were signals from the C-terminus, which
is identical in procaspase-8 and caspase-8, are presented. In contrast, signal
intensity for all regions affected by processing is below 5% of their initial val-
ues. Unfortunately, the time resolution is insufficient to allow distinguishing
whether events occur simultaneously or in sequential order.
82 CHAPTER 4. FROM PROCASPASE-8 TO CASPASE-8
Figure 4.1: Processing of procaspase-8 into caspase-8. Labeled procaspase-8
was incubated in a 1:10.000 ratio with unlabelled caspase-8. Cleavage was
monitored simultaneously by SDS PAGE and NMR.
A) SDS PAGE with procaspase-8 samples obtained at indicated time points
during the cleavage process.
B) Regions of 1D proton spectra displaying the methyl region recorded at
indicated time points.
C) Time course of signal decrease in [15N, 1H]-TROSY spectra. Peak in-
tensities present averages for all residues from the segment indicated on the
plots. Error bars reflect the standard deviation from the mean.
4.3.2 Caspase-8 undergoes structural changes during pro-
cessing and during inhibitor binding
Processing of procaspase-8 into caspase-8 is accompanied by large spectral
changes that are difficult to interpret. Furthermore, during the long mea-
surement time protein precipitated resulting in a decrease in protein concen-
tration leading to a reduction in signal intensity. Therefore, we decided to
characterize the product of the cleavage reaction in its purified form. Ac-
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Figure 4.2: Comparison of [15N, 1H]-TROSY spectra of procaspase-8
(C285A) at the beginning and the end of cleavage reaction.
cordingly, caspase-8 was prepared from the active wild-type procaspase-8 in
15N,2H-labelled form. spectra recorded on the cleavage-incompetent C285A
procaspase-8 mutant and caspase-8 indicates that both proteins are struc-
turally highly similar (Figure 4.3A). Only signals corresponding to the loops
and the linker as well as from residues of the β strand 5 and 6, which in
procaspase-8 are in close proximity to the intact linker, were significantly
shifted in position. In addition, β strand 6 forms the dimerization interface
in active caspase-8, and therefore residues from these strands are expected
to experience chemical shift changes.
During processing, the oligomerization state of the enzyme changes (Ta-
ble 4.1) At the approximate concentration used in the NMR experiments
procaspase-8 is purely monomeric whereas caspase-8, that is known to ex-
ist in a concentration-dependent monomer/dimer equilibrium [67,110], is
present as a dimer at 81%. The increasing population of dimeric states
during caspase-8 activation is also apparent from the line-widths of methyl
signals in proton spectra (Figure 4.3B). In addition, the peaks are shifted
in position indicating that they belong to residues undergoing structural
changes or become involved in forming intermolecular contacts.
Structural information is available for procaspase-8 and inhibitor-bound cas-
pase-8 but not for the inhibitor-free enzyme. The above-described data al-
lows comparing caspase-8 in its zymogen and in the inhibitor-free state. In
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Figure 4.3: Comparison of procaspase-8 (black) with caspase-8 in the ab-
sence (blue) and presence (red) of the tetrapeptide DEVD inhibitor.
A) Overlay of a [15N, 1H]-HSQC spectrum with [15N, 1H]-TROSY spec-
tra of caspase-8 in the absence or presence of the Ac-DEVD-cmk inhibitor.
Differences in peak positions indicate changes in the environment of the cor-
responding amide moieties due to conformational changes or contacts to the
inhibitor.
B) Section of the high-field region of a 1D proton spectrum displaying methyl
signals. Line-widths are correlated with protein size such that increasing
molecular weight during dimerization results in broader lines. Furthermore,
differences in peak positions were observed as also seen in A).
C) Thermal denaturation of procaspase-8 and caspase-8 before and after in-
hibitor binding followed by CD spectroscopy. CD signals recorded at 222 nm
were used to calculate the fraction of folded protein. The melting tempera-
tures for the individual proteins are indicated in the plot.
order to assess how the free enzyme differs from the published inhibitor-
bound crystal structure we added the irreversible Ac-DEVD-cmk inhibitor
and monitored changes by chemical shift mapping. Interestingly, significant
changes in peak positions occur. Analysis of the crystal structure of DEVD
bound to caspase-8 reveals that about 21 amino acids are either directly
involved in inhibitor binding or are in close vicinity. Surprisingly, compari-
son of the [15N, 1H]-TROSY spectra of caspase-8 in presence and absence of
the inhibitor reveals that more than 70 peaks are shifted, suggesting further
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Mutant Sedimentation coefficient [Sexp] Monomer/Dimer [%]
Constructs used in NMR experiments (800 µM)
Procaspase-8 2.5 ± 0.031 / — 100 / —
Caspase-8 2.3 ± 0.022 / 3.9 ± 0.035 19 / 81
Caspase-8 + DEVD 2.2 ± 0.021 / 3.5 ± 0.034 11 / 89
Constructs used in cleavage experiments (250 µM)
Procaspase-8 2.5 ± 0.019 / 3.7 ± 0.029 33 / 67 (29 / 71)*
D374A (C285A) 2.4 ± 0.019 / 3.9 ± 0.031 44 / 56
D384A (C285A) 2.7 ± 0.018 / 3.8 ± 0.025 67 / 33
F468A 2.5 ± 0.019 / — 100 / —
Table 4.1: Data derived from analytical ultracentrifugation of constructs
used for the NMR and the cleavage experiments. Samples were measured at
concentrations of 800 µM and 250 µM for NMR and cleavage experiments,
respectively. Constructs used for the cleavage experiments harbor the active
site mutation C285A and were processed by caspase-8 addition at a 1:1000
ratio. *The value in brackets was obtained previously at the same concentra-
tion for active caspase-8 which underwent autoproteolytic processing [110].
structural changes to take place upon inhibitor binding. Considering that
the majority of the secondary structure elements are identical it is likely
that these peaks belong to the active site forming loops or be located at the
dimerization interface. However, the population of the dimer in presence vs.
absence of inhibitor as determined by analytical ultracentrifugation is 81%
and 89% (Table 4.1), respectively, and hence the difference is too small to
explain the changes observed in the spectra. Moreover, a number of new
peaks appear with rather strong intensity that must belong to residues in
more flexible regions such as the active site forming loops.
To access the influence of activation and inhibitor binding on the overall
protein stability the melting points of the proteins were determined by CD
spectroscopy (Figure 4.3C). Dimerization and cleavage of the zymogen re-
sults in improved protein stability characterized by a 6.6 degree increase in
the melting temperature for caspase-8 compared to procaspase-8. An even
more pronounced stabilizing effect was observed upon inhibitor binding to
caspase-8, which elevates the melting temperature by approximately 20 de-
grees.
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Figure 4.4: Overview of caspase-8 mutants used in this study indicating
positions of individual mutation sites.
4.3.3 Determinants of the processing rate of procaspase-8
In the following we analyze to which extent the rate of processing of procas-
pase-8 by the addition of catalytic amounts of the active enzyme is influenced
by the propensity for dimerization, by phosphorylation of procaspase-8 and
by insufficient cleavage of the intersubunit linker. Therefore, we mutated
either one of the Asp cleavage motifs in the linker, introduced a mutation at
the dimerization interface or phosphorylated procaspase-8 in vitro (Figure
4.4). In order to prevent self-activation the constructs harbor an additional
C285A mutation. To all mutants active caspase-8 was added in catalytic
amounts (1:1000), the reaction was stopped at indicated time points, and
the rate of processing was analyzed by SDS PAGE and densitometry.
Over time the intensity of the bands corresponding to full-length protein
decreased and new bands for p18/p19 and p11/p12 subunits became visi-
ble. Integration of the bands corresponding to full-length protein revealed
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a double-exponential decay (Figure 4.5 A). While the procaspase-8 mutants
are rapidly processed in the beginning of the experiment cleavage rates are
reduced later on. We believed this to be mainly due to a decrease in en-
zymatic activity of caspase-8 over time and therefore we determined the
activity of caspase-8 using the fluorogenic Ac-DEVD-AMC substrate. After
3000 minutes caspase-8 retains 1% of its original activity (Figure 4.5B). The
same experiment was performed by further addition of 1000 equivalents of
the procaspase-8 mutant C285A-DDAA that cannot be cleaved due to the
double mutation D374A D384A (DDAA) and also cannot process other sub-
strates. This mutant does not compete with the Ac-DEVD-AMC substrate
for the active site of caspase-8 in contrast to procaspase-8. Surprisingly,
addition of C285A-DDAA resulted in increased caspase-8 activity (Figure
4.5C) and retarded caspase-8 deactivation (Figure 4.5B) indicating that it
is able to interact with caspase-8, most likely via heterodimerization. Fur-
thermore, analytical ultracentrifugation revealed that the affinity for dimer
formation in cleaved procaspase-8 is only slightly lower than for caspase-8
(Table 4.1).
Despite the time dependent deactivation of caspase-8, a comparison of the
cleavage efficiencies for the various substrates can still be made because
all cleavage reactions have been performed under identical conditions and
hence deactivation of caspase-8 and therefore remaining active caspase-8 is
expected to be comparable at identical time points. Interestingly, all the ana-
lyzed mutants are less efficient in processing when compared to procaspase-8.
While initial processing rates are similar within the range of the experimen-
tal error pronounced differences are observed after approx. 5-10 hours. In
case of the Asp mutants the processing rate is more strongly affected for
D384A. Analytical ultracentrifugation data of the cleavage products of both
mutants reveals that the affinity for dimerzation is impaired compared to
cleaved procaspase-8, and that this reduction is larger for D384A than for
D374A. Moreover, F468A shows a significant decrease in the processing rate
as compared to procaspase-8 underlining the important role of dimerization
for activation.
Previous studies by Cursi et al. revealed a negative effect on Fas-induced
apoptosis after phosphorylation of caspase-8 by Src kinase [83]. Src kinase
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Figure 4.5: Processing of various procaspase-8 mutants by caspase-8
A) Time course of processing for various mutants (see panel) of procaspase-8
displaying the percentage of unprocessed protein at indicated time points.
Processing was determined by SDS PAGE and densitomety on bands corre-
sponding to uncleaved enzyme.
B) Time-dependent deactivation of caspase-8 in the absence and presence of
the inactive uncleavable C285A-DDAA mutant monitored by conversion of
the fluorogenic Ac-DEVD-AMC substrate.
C) Influence of inactive uncleavable procaspase-8 C285A-DDAA on caspase-
8 activity.
D) SDS PAGE and corresponding Western blot of phosphorylated
procaspase-8 following addition of caspase-8.
phosphorylates caspase-8 specifically at Tyr380, which is located between the
two cleavage recognition motifs within the linker and is excised during pro-
cessing. In this study, we phosphorylated caspase-8 in vitro with Src kinase.
Phosphorylation of caspase-8 was detected by Western blot using a specific
phospho-tyrosine antibody (Figure 4.5D). The rate of conversion for phos-
phorylated procaspase-8 is slower than for its unphosphorylated counterpart
(Figure 4.5A). Interestingly, the band observed on SDS PAGE decreases
faster in intensity than the band on the western blot, indicating that the un-
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phosphorylated enzyme is preferably cleaved (Figure 4.5D). Phosphorylation
at Tyr380 can reduce the rate of processing and thus caspase-8 activation
and apoptosis by either sterically blocking access to the cleavage sites or by
altering the conformation of the linker.
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4.4 Discussion
Activation of inflammatory and apoptotic initiator procaspases proceeds
through dimerization, which is stabilized by subsequent proteolytic process-
ing. And although our understanding of the underlying molecular processes
has greatly advanced with the development of important concepts like the
induced-proximity model [37,108] the exact molecular details are still not
fully understood. Only a few procaspase structures are available such as
for Drosophila melanogaster Dronc [151], for executioner procaspase-7 [114],
for inflammatory procaspase-1 [152] and for procaspase-8 [110]. Much more
structural information is available on active caspases, but more than 90%
of the pdb structures are of caspases in presence of bound inhibitors. Cur-
rently, no structural information is available for inhibitor-free apoptotic ini-
tiator caspases, which exist in an equilibrium of monomers and dimers that
together with an increased flexibility of the active site forming loops and the
linker most likely prevented crystallization and impedes NMR analysis. In
contrast dimeric structures for caspase-1 and -7 have been published in both
the inhibitor free and inhibitor-bound states [114,150].
In this work we have investigated cleavage of procaspase-8 and subsequent
binding of substrates applying chemical shift mapping and biochemical meth-
ods. In the conducted experiments trace amounts of active caspase-8 trig-
gered conversion of procaspase-8 mutants that are deficient of autoprocess-
ing. Previous studies on procaspase-8 and caspase-8 stated that caspase-8
has no specificity for its own zymogen [64]. The experiments presented in this
work, however, clearly demonstrate processing of the zymogen after addition
of caspase-8 indicating that caspase-8 does have a specificity for procaspase-
8.
Cleavage of procaspase-8 results in an apparent increase in molecular weight
and large structural differences in the loops and at the dimerization inter-
face. In principle, cleavage can be accomplished in three different ways: i)
by an intramolecular process, ii) by an intermolecular process in which the
participating Asp and Cys residues are part of different protomers within
the same dimer (intradimeric) or iii) by an intermolecular process involving
a proximal caspase dimer (interdimeric). All constructs that were tested for
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cleavage contained the active site C285A mutation and are incapable of self-
processing and therefore require intermolecular cleavage. The observation
that an inactive, cleavage-incompetent C285A-DDAA mutant increases the
activity of caspase-8 suggests that heterodimerization between procaspase-8
and caspase-8 occurs. Considering the vast excess of the procapase-8 mu-
tants over active capase-8 (1000:1 in the biochemical and 10000:1 in the
NMR experiments) caspase-8 is more likely to associate with procaspase-8
than with itself, which supports the intra-dimeric cleavage hypothesis. In
addition, the concentration of caspase-8 was in the nanomolar range where
caspase-8 homodimer formation (Kd of ∼50 µM, [67]) is unlikely, whereas
our assay concentration of procaspase-8 (250 µM) was well above this thresh-
old. While the affinity of caspase-8 for procaspase-8 may be lower than for
caspase-8 formation of the heterodimer could result in immediate processing.
Finally, intra-dimeric attack by Cys285 is expected to be favored kinetically.
Our in vitro experiments support this view since they reveal a correlation
between dimerization and cleavage of the substrate. Processing is slowed
down in the dimerization-incompetent F468A mutant. Although F468A is
incompetent for homo-dimerization because cross-strand intermolecular in-
teractions of Phe468 with Pro466 have been removed, due to the pseudo-
symmetry in the heterodimer one of the two Pro-Phe contacts remain. We
expect the Kd for formation of the heterodimer to be lower than the cor-
responding value for formation of the homodimer in caspase-8, and this is
reflected in the reduced processing rate. The connection between the rate
of processing and the affinity for dimerization for the cleaved enzyme might
also explain the reduced processing rates for the cleavage mutants D374A
and D384A. Both mutants display a reduction in dimerization affinity, which
is more pronounced in the slower processing D384A mutant.
If such intra-dimeric attack takes place the linker must undergo a dramatic
conformational change in order to bring Asp374 and Asp384 into proximity
of the catalytic Cys285 from the other protomer. One plausible scenario is
that the relocation of the linker is triggered by dimerization that pushes loop
4 and possibly loop 5 towards that active site thereby displacing the linker
segment from that region. We noticed that resonances from loops 4 and 5
were completely absent in the 15N, 1H-correlation spectra of procaspase-8,
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indicating that these two loops interconvert between at least two different
states, and hence intrinsically sample a larger conformational space [110].
The proposed conformational change is very large but precedence for such a
linker topology is found in the crystal structure of procaspase-1. Although
procaspase-1 is monomeric in solution it was crystallized as a dimer with the
linker located in a cleft at the dimer interface and the cleavage motif for the
first processing site positioned close to the active site of the second protomer
(Figure 4.6 C, [152]). Furthermore, the linker in procaspase-1 is similarly
positioned as the cleaved linker of active caspase-1 and -8 (Figure 4.6 A).
Loops 3 and 4 (corresponding to loops 4 and 5 in procaspase-8) are slightly
shifted towards the active site supporting their role in linker displacement.
Thus the structure of the procaspase-1 displays all structural elements that
are required for the proposed mode of cleavage for procapase-8 and we have
taken this as a model of how the structure of procaspase-8 could change
during dimerization.
Previous studies state that dimerization is the prime event in initiator cas-
pase activation that triggers structural rearrangements of the active site
forming loops leading to formation of the active site [36,67,108,110,117,118].
Our chemical shift mapping experiment using the DEVD inhibitor indicates
that dimerization is not sufficient to form a proper active site, and that ad-
ditional significant changes occur upon inhibitor binding. This statement
is supported by similar conclusions drawn from the comparison of crystal
structures of caspase-1 and caspase-7 in presence or absence of inhibitors
and their corresponding zymogens [114,150]. In both enzymes structural
differences are observed in the active site forming loops 3 and 4 and in the
linker fragments with the inhibitor-free form being a structural intermediate
between the zymogen and the inhibitor-bound species (Figure 4.6 B). More-
over, loops 3 and 4 are arranged in a way that the substrate-binding pocket
is not properly formed in the absence of inhibitors. Furthermore, the cleaved
linker fragments L2 and L2’ of the associated protomers interact with each
other in all inhibitor-bound crystal structures while they are separated in
inhibitor-free caspase-7 [114]. Mutants of caspase-8 in which the L2 loop
is truncated experience a significant shift towards the monomeric state for
caspase-8 suggesting their importance for dimer stabilization [110]. Struc-
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Figure 4.6: Comparison of different caspase activation states.
A) Superposition of procaspase-1 (blue, pdb code 3E4C) and caspase-1 in
the absence (green, pdb code 1SC1) and presence (red, pdb code 1IBC) of
a tetrapeptidic WEHD inhibitor (yellow). The active site forming loops are
labeled and indicated in bright colors. The tetrapeptidic inhibitor is pre-
sented as sticks.
B) Superposition of procaspase-7 (pdb code 1K88) and caspase-7 in the ab-
sence (pdb code 1K86) and presence (pdb code 1F1J) of a tetrapeptidic
DEVD inhibitor. The color coding and labeling is the same as described in
A).
C) Comparison of the linker orientation in dimeric procaspase-1 (brown)
and monomeric procaspase-8 (blue, pdb code 2K7Z). The active site
cysteine and the Asp residues in the cleavage motifs are presented as
sticks. All figures were prepared using PyMol (DeLano Scientific LLC,
http://www.pymol.org).
tural differences of the L2 loop between inhibitor-free and inhibitor-bound
caspase-8 could explain the higher dimer affinity upon inhibitor binding, a
common phenomenon for initiator caspases [67].
Previous experiments on caspase-7 revealed an increased overall protein sta-
bility upon inhibitor binding by 17.9 degrees [153], which is in the same range
as observed for caspase-8. Since caspase-7 is dimeric both in the absence
and presence of inhibitor the enhanced stability must be largely indepen-
dent from dimerization. Therefore, we speculate that the increased overall
stability of caspase-8 upon addition of the inhibitor is rather due to rigid-
ification of the loops around the active site and possibly may also involve
loop4 and 5, which in procaspase-8 undergo conformational exchange [110].
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Figure 4.7: Schematic drawing of the caspase-8 activation mechanism. The
large and small subunits are indicated by large and small boxes, respectively.
The active site forming loops and the linker are depicted as lines and labeled
according to the nomenclature used in Keller et al. 2009 [110].
Further support for the induced fit mechanism can be found in the structure
of dimeric caspase-9, where only one active site is occupied by the inhibitor
revealing a different conformation when compared to the empty site in the
other protomer [118]. Although the authors suggested that the unoccupied
site resembles the zymogen conformation, it might as well be a structural
intermediate between the zymogen and the inhibitor-bound form. Further-
more, structural differences between inhibitor-free and inhibitor-bound form
were also observed for caspase-3 [154]. In that case, however, conformational
differences are restricted to side chains (especially 3 hydrophobic residues lin-
ing the S2 pocket). These observations together with our data suggest that
substrate binding to the active site pocket during caspase activation proba-
bly generally occurs via an induced-fit mechanism. Whether the changes in
caspase-8 involve larger conformational changes of the loops as observed for
caspase-1 and -7 or minor side chain rearrangements as seen in caspase-3 can-
not be distinguished based on our experiments. However, the data confirm
that dimerization is the prime event during caspase-8 activation and allow
expanding the current model of initiator caspase activation (Figure 4.7).
We propose that dimerization helps relocating the cleavage motifs within
the linker to become accessible for intermolecular cleavage and initiates pre-
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building of the active site, which finally forms upon substrate binding.
Caspase-8 activation at the DISC is a very complex issue that is difficult to
address in vitro and certainly requires additional biochemical experiments
under conditions that better mimic the DISC environment. The model for
caspase-8 activation proposed in this work provides a working hypothesis
that may help guiding the design of such experiments.
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4.5 Materials and Methods
4.5.1 Protein design, expression and purification
The DNA sequence coding for human caspase-8 amino acids 217-479 was
cloned into a pQE50 vector (Qiagen). Amino acid substitutions were gen-
erated by QuikchangeTM mutagenesis (Stratagene) mutagenesis. The plas-
mids were transformed into M15 (pREP4) cells (Qiagen), and the protein
was expressed at 37◦C overnight either in LB (unlabeled protein) or in M9
(15N-labeled protein) medium. M9 minimal media was supplemented with
15NH4Cl as the sole nitrogen source. Deuteration was achieved by growing
cells in D2O.
The purification protocol was adapted from published procedures [66] and
was described previously [110]. Cells were harvested, resuspended in PBS
buffer and lyzed by french press. The soluble protein fraction was removed by
centrifugation, inclusion bodies washed in 20 mM Tris pH 8.0, 1 mM EDTA,
0.1% LDAO and solubilized in 6.5 mM GdHCl, 20 mM Tris pH 8.0, 2 mM
EDTA, 100 mM DTT. The solubilized inclusion bodies were added to an
equal volume of acetic acid and the sample dialyzed against 50% acetic acid.
Subsequently the solution was suspended rapidly in nine volumes H2O and
immediately diluted in nine-fold excess of 1 M Tris pH 8.0, 5 mM DTT. Re-
folding was performed over night at room temperature and aggregates were
removed by centrifugation. Final purification was achieved by size exclusion
chromatography on a Superdex 200 column (Amersham) using 20 mM Tris,
pH 8.0, 100 mM NaCl, 10% sucrose, 0.5 mM TCEP. In this buffer the protein
can be stored at -80◦C. Light-scattering was used to confirm monodispersity
of the refolded purified sample.
4.5.2 NMR experiments
NMR samples were rebuffered into 20 mM deuterated Tris pH 8.0, 100
mM KCl, 10 mM DTT. Procaspase-8 that was used to monitor the time-
course of cleavage and active caspase-8 were both 2H, 15N-labeled. The irre-
versible tetrapeptidic AC-DEVD-cmk inhibitor was added in five-fold excess
to 2H, 15N-labelled active caspase-8. All NMR experiments were recorded at
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305 K on a Bruker Avance 700 MHz spectrometer, equipped with a triple-
resonance cryoprobe. [15N, 1H]-HSQC and [15N, 1H]-TROSY experiments
were recorded during cleavage for monomeric proteins and of dimeric caspase-
8 using, respectively. The spectra were processed in Topspin2.1 (Bruker) and
transferred to CARA for spectral analysis [134]. Complete processing at both
cleavage sites was confirmed by MALDI mass spectroscopy.
4.5.3 Analytical ultracentrifugation
Analytical ultracentrifugation was performed with an Optima XL-1 cen-
trifuge (Beckman Coulter) and a TI50 rotor using epoxy centerpieces (12
mm) with sapphire windows. Samples were run at 20◦C and 42000 rpm.
Absorption was measured between 280 and 315 nm, depending on protein
concentration. Results were analyzed using Sedfit [143].
4.5.4 CD Spectroscopy
Thermal denaturation was performed on a Jasco J-715 spectropolarimeter
equipped with a temperature control unit. The concentrations of the samples
were 100 µM using a quartz cuvette with a 1 mm path length. Data points
were taken at 222 nm while increasing the temperature by 1◦C/min from
5◦C to 95◦C. The band-width was set to 1 nm and the response time to 4 s.
4.5.5 In vitro cleavage experiments
All proteins were dialyzed against phosphorylation buffer (50 mM Tris pH
8.0, 150 mM NaCl, 0.5 mM TCEP, 20 mMMgCl2, 12.5 mMMnCl2, 12.5 mM
β-glycrolphosphate). Phosphorylation of procaspase-8 was accomplished by
incubation with Src kinase (SignalChem) with 25-fold excess of procaspase
and 5 fold excess of ATP at 37◦C for 3 hrs. Small amounts of precipi-
tated protein were removed by centrifugation. The final sample volume for
monitoring the cleavage reaction was 200 µlcontaining 250 µMprocaspase-8
mutants. The reaction was started by addition of 250 nM caspase-8. Small
aliquots were removed at indicated time points, immediately suspended in
hot 5x SDS loading buffer and incubated for 5 min at 95◦C. The cleavage
educts and products were separated by SDS PAGE. The gels were scanned
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in a Fuji LAS 3000 image reader (FujiFilm) and the bands corresponding
to full-length caspase-8 analyzed by densitometry using the AIDA image
analyzer software. The obtained values were normalized by setting the con-
centration of full-length protein at the beginning of the reaction to 100% and
by appropriate scaling of all subsequent data. Measurements were performed
in triplicate and the standard deviations were calculated. Initially we tried
to fit the kinetic data against single-exponentially decaying functions but
discovered that data could not be fit well due to inactivation of caspase-8.
Inactivation of caspase-8 in the absence and presence of PC8 DDAA was
determined by addition of the Ac-DEVD-AMC substrate at a final concen-
tration of 100 µM. The concentrations of the proteins and the buffer were
the same as used in the cleavage reactions described above. Measurements
were performed in triplicate in black 96-well Nuncion microtiter plates using
the Magellan6 software on a GENios plate reader (Tecan). AMC release was
monitored by its fluorescence at 465 nm following excitation at 360 nm.
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Appendix A
Protein sequences
A.1 Caspase-8 mutants
A.1.1 Full-length caspase-8
The following constructs were cloned into pCR3-vectors for mammalian
cell expression. Point mutations for C130S and C163S were generated by
Quikchange mutagenesis. All constructs contain an C-terminal myc-tag (un-
derlined) for detection purposes. The cysteine to alanine mutations and the
active site cysteine are indicated by boxes. In the corresponding PC8 con-
structs the active site cysteine was mutated to alanine
C8-myc - MW = 56834.6 Da, 280 = 33070
PC8-myc - MW = 56802.5 Da, 280 = 33070
MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLK
ELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSFKFLLQE
EISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKIINDYEEFSKERSSSL
EGSPDEFSNGEELCGVMTISDSPREQDSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVP
KLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCIL
SHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQA C QGDNYQKGIPVETDSEE
QPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDIL
TILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDSGEQKLISEEDLN
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C8 C130S-myc - MW = 56790.4 Da, 280 = 33070
PC8 C130S-myc - MW = 56758.3 Da, 280 = 32945
MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLK
ELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSFKFLLQE
EIS NSN LDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKIINDYEEFSKERSSS
LEGSPDEFSNGEELCGVMTISDSPREQDSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKV
PKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCI
LSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQA C QGDNYQKGIPVETDSE
EQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDI
LTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDSGEQKLISEEDLN
C8 C163S-myc - MW = 56818.5 Da, 280 = 33070
PC8 C163S-myc - MW = 56786.5 Da, 280 = 32945
MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLK
ELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSFKFLLQE
EISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRV S AQINKSLLKIINDYEEFSKERSSS
LEGSPDEFSNGEELCGVMTISDSPREQDSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKV
PKLHSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCI
LSHGDKGIIYGTDGQEAPIYELTSQFTGLKCPSLAGKPKVFFIQA C QGDNYQKGIPVETDSE
EQPYLEMDLSSPQTRYIPDEADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDI
LTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSDSGEQKLISEEDLN
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A.1.2 Prodomain of caspase-8
The following constructs were cloned into pET-20b(+) vectors (Invitrogen)
[99]. Point mutations for C130S and C163S were generated by Quikchange
mutagenesis. The TEV cleavage site (underlined) was cloned into a BamH I
located directly in front of the DED sequence. Mutations are indicated by
boxes. All constructs contain an N-terminal GB1-tag for enhanced solubility
and a C-terminal His-tag for purification and detection purposes. Purifica-
tion was performed as described on page 127.
Single domains
GB1-DED1-His - MW = 17569.8 Da, 280 = 14440
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSMDFSR
NLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEESNLSFLKELLFR
INRLDLLITYLNTRKELEHHHHHH
GB1-DED2-His - MW = 17870.3 Da, 280 = 14565
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSMPGRA
QISAYRVMLYQISEEVSRSELRSFKFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDI
LKRVCAQINKSLLKIINDYEELEHHHHHH
GB1-DED2 C130S-His - MW = 17826.1 Da, 280 = 14440
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSMPGRA
QISAYRVMLYQISEEVSRSELRSFKFLLQEEIS NSN LDDDMNLLDIFIEMEKRVILGEGKLD
ILKRVCAQINKSLLKIINDYEELEHHHHHH
GB1-DED2 C163S-His - MW = 17854.2 Da, 280 = 14440
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSMPGRA
QISAYRVMLYQISEEVSRSELRSFKFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDI
LKRV S AQINKSLLKIINDYEELEHHHHHH
122 APPENDIX A. PROTEIN SEQUENCES
Double domains
His-GB1-TEV-DED12 - MW = 29758.8 Da, 280 = 20400
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSENLYF
Q - GGSDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEES
NLSFLKELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSF
KFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKIINDYEELEH
HHHHH
His-GB1-TEV-DED12 C130S - MW = 29714.6 Da, 280 = 20400
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSENLYF
Q - GGSDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEES
NLSFLKELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSF
KFLLQEEIS NSN LDDDMNLLDIFIEMEKRVILGEGKLDILKRVCAQINKSLLKIINDYEELE
HHHHHH
His-GB1-TEV-DED12 C163S - MW = 29742.8 Da, 280 = 20400
MQYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTEGSENLYF
Q - GGSDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQEKRMLEES
NLSFLKELLFRINRLDLLITYLNTRKEEMERELQTPGRAQISAYRVMLYQISEEVSRSELRSF
KFLLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRV S AQINKSLLKIINDYEELE
HHHHHH
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A.1.3 Catalytic domain of caspase-8 – single-chain constructs
The following single-chain constructs were cloned into pQE-50 vectors (Qi-
agen). Single amino acid mutations are indicated by boxes. Purification
was performed as described on page 129. ’ - ’ indicate the cleavage sites at
which the constructs are autocatalytically processed during the purification
procedure.
Unprocessed caspase-8 – MW = 30340.4 Da, 280 = 24005
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETD - SEEQPYLEMD - LSSPQTRYIPDE
ADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNM
GKQMPQPTFTLRKKLVFPSD
Processed caspase-8 - C8 – MW = 29118.1 Da, 280 = 22515
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETD - LSSPQTRYIPDEADFLLGMATVNNC
VSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRK
KLVFPSD
Procaspase-8 - PC8 – MW = 30308.4 Da, 280 = 23880
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQA A QGDNYQKGIPVETD - SEEQPYLEMD - LSSPQTRYIPD
EADFLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKN
MGKQMPQPTFTLRKKLVFPSD
DDAA – MW = 30252.4 Da, 280 = 24005
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVET A SEEQPYLEM A LSSPQTRYIPDEADFL
LGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQM
PQPTFTLRKKLVFPSD
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D374A – MW = 30296.4 Da, 280 = 24005
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVET A SEEQPYLEMD - LSSPQTRYIPDEAD
FLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGK
QMPQPTFTLRKKLVFPSD
D384A – MW = 30296.4 Da, 280 = 24005
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETD - SEEQPYLEM A LSSPQTRYIPDEAD
FLLGMATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGK
QMPQPTFTLRKKLVFPSD
F468A – MW = 30264.3 Da, 280 = 24005
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETDSEEQPYLEMDLSSPQTRYIPDEADFLLG
MATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQ
PT A TLRKKLVFPSD
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A.1.4 Catalytic domain of caspase-8 – two-chain constructs
The following two-chain constructs were cloned separately in pET-11d vec-
tors (Invitrogen). Single amino acid mutations are indicated by boxes. Pu-
rification was performed as described on page 131.
αβ F468A – MW = 29042.0 Da, 280 = 22515
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETD - LSSPQTRYIPDEADFLLGMATVNNC
VSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPT A TLR
KKLVFPSD
β-trunc – MW = 28278.2 Da, 280 = 22515
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQ - LSSPQTRYIPDEADFLLGMATVNNCVSYRNPAE
GTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSD
α-trunc – MW = 27859.7 Da, 280 = 21025
MRGSESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKLHSIRDRNGTHLDAGALTTTFEE
LHFEIKPHDDCTVEQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPIYELTSQ
FTGLKCPSLAGKPKVFFIQACQGDNYQKGIPVETD - EADFLLGMATVNNCVSYRNPAEGTW
YIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQMPQPTFTLRKKLVFPSD
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A.2 FADD
The TEV cleavage recognition site is underlined. The protein is processed
at ’´. Purification was performed as described on page 133.
FADD – MW = 50822.2 Da, 280 = 62840
MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDV
KLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKL
PEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQI
DKYLKSSKYIAWPLQGWQATFGGGDHPPKSDLVPRENLYFQG - GSPEFRDPFLVLLHSVSS
SLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSMLLEQNDLEPGHTELLRELLASLRRHDLL
RRVDDFEAGAAAGAAPGEEDLCAAFNVICDNVGKDWRRLARQLKVSDTKIDSIEDRYPRNLTE
RVRESLRIWKNTEKENATVAHLVGALRSCQMNLVADLVQEVQQARDLQNRSGAMSPMSWNSDA
STSEAS
Appendix B
Purification protocols
B.1 Caspase-8 prodomain
The protocol was adapted from Ghisleni et al. [99].
Day -4:
• Transform pET plasmids (Amp) into BL21(DE3) cells
Day -3:
• Set up 10 ml ON culture (Amp)
Day -2:
• Inoculate 2 x 500 ml LB (Amp) with 5 ml ON culture each
• Grow at 37◦C until OD6000¯.5
• Induce with 1 mM IPTG
• Express at 37◦C for 4 hours
Day -1:
• Harvest at 5 K for 20 min
• Resuspend cells in 25 ml Ni-buffer A
• Freeze at -20 or proceed with Day 1
Day 1:
• Thaw cells
• Add DNaseI
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• French press
• Centrifuge at 24,000 x g for 30 min
• Load soluble protein onto Ni column equilibrated with Ni-buffer A
• Wash out unbound protein with wash buffer
• Elute with Ni-buffer B
Buffers (adjusted for a 1000 ml prep):
Ni-buffer A
50 mM Tris 8.0
100 mM NH4Cl
0.5 mM TCEP
Wash buffer
50 mM Tris 8.0
100 mM NH4Cl
0.5 mM TCEP
20 mM Imidazole
Ni-buffer B
50 mM Tris 8.0
100 mM NH4Cl
0.5 mM TCEP
200 mM Imidazole
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B.2 Caspase-8 catalytic domain – single chain con-
structs
The protocol was adapted from Watt et al. and adjusted for a prep starting
from 1000 ml cell culture [66].
Day -4:
• Transform pQE plasmid (Amp) into M15 cells (Kan)
Day -3:
• Set up 10 ml ON culture (Amp/Kan)
Day -2:
• Inoculate 2 x 500 ml LB (Amp/Kan) with 5 ml ON culture each
• Grow at 37◦C until OD6000¯.8-1.0
• Induce with 1 mM IPTG
• Express at 37◦C ON
Day -1:
• Harvest at 5 K for 20 min
• Resuspend cells in 25 ml PBS
• Freeze at -20 or proceed with Day 1
Day 1:
• Thaw cells
• Add DNaseI
• French press
• Pellet IB at 8,000 x g for 20 min
• Wash 4 x 25 ml with wash buffer or until clear
• Solubilize in 5 ml solubilization buffer (store at -70)
• Add 5 ml 100% AcOH
• Dialyze against 50% AcOH for 4 hrs (with buffer exchanges)
• Add to 90 ml H2O
• Refold at RT ON in 900 ml refolding buffer
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Day 2:
• Remove precipitation by centrifugation
• Concentrate in 400 ml Amicon
Day 3:
• Purify on S200 column
Buffers (adjusted for a 1000 ml prep):
Wash buffer (100 ml)
20 mM Tris 8.0
0.1% LDAO
1 mM EDTA
Solubilization buffer (5 ml)
6 M GdHCl
20 mM Tris pH 8.0
2 mM EDTA
100 mM DTT
Refolding buffer (900 ml)
1 M Tris
10 mM DTT
1 Protease inhibitor tablet (Roche)
Size exclusion buffer (1000 ml)
20 mM Tris 8.0
100 mM NaCl
0.5 mM TCEP
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B.3 Caspase-8 catalytic domain – two-chain con-
structs
The protocol was adapted from Garcia-Calvo et al. adjusted to a prep start-
ing from 500 ml cell culture [123].
Day -4:
• Transform pAT22-PC2 + BirA into BL-21(DE3)
• Plate on LB Amp/Cam
• Incubate at 37◦C ON
Day -3:
• Pick colony for ON culture
Day -2:
• Inoculate 500 ml LB Amp/Cam with 5 ml ON culture
• Grow until OD600 = 0.5 • Induce with 1 mM IPTG
• Express at 37◦C ON
Day -1:
• Harvest at 5 K for 20 min
• Resuspend cells in 25 ml PBS
• Freeze at -20 or proceed with Day 1
Day 1:
• Thaw cells
• Add DNaseI
• French press
• Pellet IB at 8,000 x g for 20 min
• Wash 4 times 25 ml with wash buffer or until clear
• Solubilize in 2.5 ml solubilization buffer
• Store at -70 or proceed with Day 2
Day 2:
• Refold into 200 ml Refolding buffer
• Incubate ON at RT
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Day 3:
• Remove precipitation by centrifugation
• Concentrate in Amicon filtration cell
• Dialyze against ResQ buffer A
Day 4:
• Load onto ResQ
• Elute with gradient of 0 - 300 mM NaCl over 30 CV
• Concentrate positive fractions
• Purify on S200 column
Buffers (adjusted for two 500 ml preps or one 1000 ml prep):
Wash buffer (100 ml)
20 mM 1M Tris 8.0
0.1% LDAO
1 mM EDTA
Solubilization buffer (5 ml)
6 M GdHCl
20 mM Tris pH 8.0
2 mM EDTA
100 mM 1M DTT
Refolding buffer (900 ml)
100 mM HEPES 7.5
10 mM NaCl
Size exclusion buffer (150 ml)
20 mM Tris 8.0
100 mM NaCl
0.5 mM TCEP
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B.4 FADD
The protocol was adapted from Ghisleni et al. [99].
Day -4:
• Transform pGEX plasmid (Amp) into BL21(DE3) cells
Day -3:
• Set up 10 ml ON culture (Amp)
Day -2:
• Inoculate 2 x 500 ml LB (Amp) with 5 ml ON culture each
• Grow at 37◦C until OD6000¯.5
• Induce with 1 mM IPTG
• Express at 18◦C over night
Day -1:
• Harvest at 5 K for 20 min
• Resuspend cells in 25 ml Buffer A
• Freeze at -20 or proceed with Day 1
Day 1:
• Thaw cells
• Add DNaseI
• French press
• Centrifuge at 24,000 x g for 30 min
• Load soluble protein onto GST trap column equilibrated with Buffer A
• Wash out unbound proteins with buffer A
• Elute with Buffer B
Buffers (adjusted for a 1000 ml prep):
Ni-buffer A
50 mM Tris 8.0
150 mM NaCl
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Ni-buffer B
50 mM Tris 8.0
10 mM reduced glutathione
Appendix C
Crystallization of Bcl-xl
The goal of this project was to crystallize the anti-apoptotic protein Bcl-
xl with a small molecule inhibitor that was selected from a DNA-encoded
chemical library [155]. Several specific binders were selected for Bcl-xl with
the compound 19/93 binding with the hightest affinity (0.93 µM; Melkko,
S. unpublished results). Competition assays using an excess of Bak-derived
BH3 peptide suggest binding of the inhibitor to the same peptide binding
cleft that is occupied by the natural BH3 peptide.
C.1 Protein purification, crystallization and data
collection
The protein Bcl-xl was expressed and purified by Alessandra Villa from the
group of Dario Neri at the Institute of Pharmaceutical Science at the ETH
Zurich. Purification included Ni-NTA affinity purification, dialysis against
Mes buffer pH 6.0 and size exclusion chromatography using an S200 column
and resulted in pure and homogeneous material (Figure C.1).
The protein was concentrated to 1 mM and crystallization was set up using
a Phoenix liquid handler (Art Robbins Instruments). The crystallization
buffer contained Mes and ammonium sulfate and was adapted from pub-
lished conditions [156]. The pH of the Mes buffer varied from 5.5 to 6.5
and ammonium sulfate was used in concentrations from 1.6 to 2.2 M. First
crystals at both, 4◦C and 20◦C appeared after one week of incubation and
were fully grown after 2-3 weeks (Figure C.2). Nucleation of crystal growth
was higher at 4◦C resulting in more but smaller crystals than compared to
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Figure C.1: Purification of Bcl-xl.
A) SDS PAGE showing different steps of the Bcl-xl purification. The indi-
vidual steps are indicated above the lanes.
B) Analytical size exclusion chromatogram of Bcl-xl to verify protein purity
and homogeneity.
Figure C.2: Crystal growth at 4◦C and 20◦C.
20◦C where usually one to three crystals were observed.
The crystals were isolated from the drops and soaked for half a minute to five
minutes in cryo buffer (50 mM Mes pH 5.5, 2.0 mM ammonium sulfate, 10%
ethylen glycol) containing a final concentration of 10 mM of in DMSO dis-
solved 19/93 inhibotor. Addition of the inhibitor to the cryo buffer resulted
in precipitation of it but this precipitation mostly dissolved after several
hours of incubation, indicating that the inhibitor was still present in excess
to the protein. After soaking the crystals were flash frozen in liquid nitrogen.
Various crystals from 4◦C and 20◦C with different soaking conditions were
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Data collection
Beamline PXI, Swiss Light Source, PSI
λ (Å) 1.0
Spacegroup P41212
Cell parameters a = b = 63.7 Å, c = 109.9Å, α = β = γ = 90◦
Reflections
unique 272333 (90089)
observed 21679 (7059)
Redundancy 12.6 (12.8)
Resolution limit (Å) 40 - 1.8 (2.06 - 1.8)
Completeness (%)* 100 (100)
Average I/σ 37.6 (6.3)
Rsym 3.6 (49.4)
Refinement
Resolution (Å)
Rcryst/Rfree (%) 20.7 / 23.3
Number of
molecules in assymetric unit 1
protein atoms 1185
water molecules 120
inhibitor molecules 0
Ramachandran plot (Procheck)
Most vafored (%) 95.3
Allowed (%) 4.7
Generously allowed (%) 0
Disallowed (%) 0
Root mean square deviations
bond length (Å) 0.004
Bond angles (degrees) 0.795
Table C.1: X-ray data collection and refinement statistics.
The data of the highest resolution shell are displayed in parentheses. Rfree
represents the R factor calculated using 6% of the data that were excluded
from the refinement.
tested at the Swiss Light Source Synchroton at the Paul Scherer Institute in
Villingen and data sets were recorded for diffracting crystals.
C.2 Structure determination
The data were processed and scaled in XDS and XSCALE, respectively [157].
The processing statistics are summarized in Table C.1. The determined
space group, P41212 corresponds to a previously published Bcl-xl structure
(PDB code 1R2D). Both structure also have very similar unit cell parame-
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Figure C.3: Bcl-xl structure
A) Electron density maps contoured at 1.5 σ. Presented is a hydrophobic
pocket which was previously found to be involved in inhibitor binding. One
Bcl-xl molecule is depicted in green. A second molecule is represented in
blue. Due to crystal packing a loop of the cyan molecule protrudes into the
hydrophobic binding pocket.
B) Structure of Bcl-xl. The helices are colored in rainbow from blue at the
N-terminus to red at the C-terminus. A) and B) are displayed in the same
orientation.
ters. Therefore, this structure was used as a searched model for molecular
replacement using the programm Phaser [158]. The model was refined in
Phenix [159] and was build using Coot [160].
Due to time constraints the structure could not yet be fully refined. The
current refinement statistics are listed in Table C.1 and the corresponding
structure is diplayed in Figure C.3 B. Unfortunately, no electron density for
the inhibitor was detected. Figure C.3 A depticts the electron density map of
the region where inhibitor binding was expected. Interestingly, this region
is involved in crystal contacts with a neighboring molecule with a loop of
the second molecule protruding into the substrate binding pocket, partially
occupying it. This indicates that the current approach of soaking wild-type
crystals with the inhibitor is impossible. Therefore, co-crystallization exper-
iments were set up to screen for new crystallization conditions.
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